var title_f32_15_33008="Azelastine: Drug information";
var content_f32_15_33008=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Azelastine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12618204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?7/53/8022?source=see_link\">",
"       Azelastine (nasal): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/47/17139?source=see_link\">",
"       Azelastine (ophthalmic): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8798 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-7727F3B860-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33008=[""].join("\n");
var outline_f32_15_33008=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?7/53/8022?source=related_link\">",
"      Azelastine (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/47/17139?source=related_link\">",
"      Azelastine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_15_33009="Hip abduction PI";
var content_f32_15_33009=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F67013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F67013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hip abduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 322px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    As above, you will need a piece of rubber tubing or elastic band. Stand with the legs shoulder width apart, with the \"good\" leg closest to the furniture or door. The tubing should loop around the outside of the injured leg. Lift the affected leg to the side, 18 to 24 inches away from the body, stretching the tubing. Hold for 5 seconds, then slowly release. Rest as needed. Repeat 10 to 15 times (one set). Perform a total of 3 sets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33009=[""].join("\n");
var outline_f32_15_33009=null;
var title_f32_15_33010="Patient information: Pleural mesothelioma (The Basics)";
var content_f32_15_33010=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83443\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/17/41237\">",
"         Normal lungs",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?3/17/3347\">",
"         Patient information: Asbestos exposure (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?25/21/25939\">",
"         Patient information: Medical care during advanced illness (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/50/10018\">",
"         Patient information: Pleural effusion (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?6/46/6883\">",
"         Patient information: Shortness of breath (dyspnea) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/16/37121\">",
"         Patient information: What are clinical trials? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/50/28450\">",
"         Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pleural mesothelioma (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pleural-mesothelioma-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H107958043\">",
"      <span class=\"h1\">",
"       What is pleural mesothelioma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pleural mesothelioma is a rare type of cancer that happens in the thin layer of tissue around the lungs. This tissue is called the &ldquo;pleura&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef67527 \" href=\"mobipreview.htm?40/17/41237\">",
"       figure 1",
"      </a>",
"      ). Pleural mesothelioma is a very serious illness that gets worse over time.",
"     </p>",
"     <p>",
"      People who get pleural mesothelioma are usually older than 50. It is almost always caused by being around a mineral called &ldquo;asbestos.&rdquo; Asbestos used to be common in insulation, ceiling tiles, car brakes, and many other materials. It is made up of very small fibers. If these fibers get into the lungs, they can cause serious health problems.",
"     </p>",
"     <p>",
"      Since the 1970s, people have mostly stopped using asbestos. That&rsquo;s because scientists learned that being around asbestos (&ldquo;asbestos exposure&rdquo;) can cause problems, including pleural mesothelioma. These problems might not happen until many years after a person is around asbestos. If you were around asbestos in the past, you could be at risk for pleural mesothelioma.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H107958058\">",
"      <span class=\"h1\">",
"       What are the symptoms of pleural mesothelioma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The main symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Shortness of breath &ndash; You might feel like you can&rsquo;t get enough air or have to work harder than usual to breathe.",
"       </li>",
"       <li>",
"        Chest pain",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Having these symptoms does not mean you have pleural mesothelioma. Many common conditions cause shortness of breath and chest pain. Most of these conditions are much more common than pleural mesothelioma.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H107958073\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you have shortness of breath, see your doctor or nurse. If you have chest pain and a lot of trouble breathing, you need to go to the hospital. Those symptoms could mean that your condition is serious.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H107958088\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse will do an exam and learn about your symptoms. You might have some or all of these tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Chest X-ray and other imaging tests &ndash; These might include a CT scan, PET scan, or MRI. All these tests create pictures of your lungs and the area around them.",
"       </li>",
"       <li>",
"        Breathing tests &ndash; In these tests, you breathe hard into a tube. The tests show how well your lungs are working.",
"       </li>",
"       <li>",
"        Bronchoscopy &ndash; A doctor uses a thin tube (called a &ldquo;bronchoscope&rdquo;) to look inside your airways.",
"       </li>",
"       <li>",
"        Biopsy &ndash; A doctor takes a small sample of tissue from the pleura or the space between your lungs. Another doctor looks at the sample under a microscope to check for mesothelioma.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H107958105\">",
"      <span class=\"h1\">",
"       How is pleural mesothelioma treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors cannot always get rid of pleural mesothelioma. But they can give treatments that might help you breathe better or have less pain. These include: &nbsp;",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Surgery &ndash; Many people with pleural mesothelioma are not healthy enough for surgery, but a few people are. During surgery, doctors might:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Take out some (or all) of the tissue that has mesothelioma.",
"       </li>",
"       <li>",
"        Drain fluid from around the lung",
"       </li>",
"       <li>",
"        Put a powdery substance called &ldquo;talc&rdquo; in the space around the lung. This can help keep fluid from building up there.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Radiation therapy &ndash; Radiation kills cancer cells.",
"       </li>",
"       <li>",
"        Chemotherapy - Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people have a combination of treatments. For example, you might have radiation treatment or chemotherapy after surgery. The best treatment for you will depend on your age, health, and other symptoms. Your doctor or nurse will talk with you about the best treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H107958120\">",
"      <span class=\"h1\">",
"       Should I be in a clinical trial?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have pleural mesothelioma, you might want to be in a &ldquo;clinical trial.&rdquo; A clinical trial is a research study that tests new medicines and treatments to see how well they work.",
"     </p>",
"     <p>",
"      Being in a clinical trial might or might not change your symptoms or help you live longer. But it can give doctors more information about pleural mesothelioma and how to treat it. Information from the trial can help them create new and better medicines and treatments. To find out more about being in a clinical trial, talk with your doctor.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H107958137\">",
"      <span class=\"h1\">",
"       What will my life be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on your age, health, treatment, and other factors. Treatment works well for some people and not as well for others.",
"     </p>",
"     <p>",
"      Knowing certain things can help you make decisions about treatment. Any time your doctor talks with you about a new treatment, ask:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        What are the benefits of this treatment? Is there a chance it could help me live longer? How much will it help my symptoms?",
"       </li>",
"       <li>",
"        What bad things could happen if I have this treatment?",
"       </li>",
"       <li>",
"        Do I have other choices besides this treatment?",
"       </li>",
"       <li>",
"        What happens if I do not have this treatment?",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H107958152\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/17/3347?source=see_link\">",
"       Patient information: Asbestos exposure (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/21/25939?source=see_link\">",
"       Patient information: Medical care during advanced illness (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/50/10018?source=see_link\">",
"       Patient information: Pleural effusion (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/46/6883?source=see_link\">",
"       Patient information: Shortness of breath (dyspnea) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/16/37121?source=see_link\">",
"       Patient information: What are clinical trials? (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/50/28450?source=see_link\">",
"       Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?32/15/33010?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83443 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-8377BC303A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33010=[""].join("\n");
var outline_f32_15_33010=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107958043\">",
"      What is pleural mesothelioma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107958058\">",
"      What are the symptoms of pleural mesothelioma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107958073\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107958088\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107958105\">",
"      How is pleural mesothelioma treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107958120\">",
"      Should I be in a clinical trial?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107958137\">",
"      What will my life be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H107958152\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83443\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/17/41237\">",
"      Normal lungs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/17/3347?source=related_link\">",
"      Patient information: Asbestos exposure (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/21/25939?source=related_link\">",
"      Patient information: Medical care during advanced illness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/50/10018?source=related_link\">",
"      Patient information: Pleural effusion (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/50/28450?source=related_link\">",
"      Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/46/6883?source=related_link\">",
"      Patient information: Shortness of breath (dyspnea) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/16/37121?source=related_link\">",
"      Patient information: What are clinical trials? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_15_33011="Gram stain lung 1C answer";
var content_f32_15_33011=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F82315&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F82315&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Legionella",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 303px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dieterle silver-stain of lung biopsy (x1000). With this stain, Legionella can be seen as small dark coccobacilli.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33011=[""].join("\n");
var outline_f32_15_33011=null;
var title_f32_15_33012="Iron dextran: Patient drug information";
var content_f32_15_33012=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Iron dextran: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/46/21222?source=see_link\">",
"     see \"Iron dextran: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/20/9542?source=see_link\">",
"     see \"Iron dextran: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F184543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dexferrum&reg;;",
"     </li>",
"     <li>",
"      INFeD&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F184544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dexiron&trade;;",
"     </li>",
"     <li>",
"      Infufer&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10023116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700213",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700898",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will be given a test dose before your first dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will be watched closely by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10023118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691725",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anemia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10023117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702325",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to iron dextran or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703226",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Anemia from a cause other than low iron stores, too much iron in your body, or thalassemia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10023122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have rheumatoid arthritis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696892",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take other iron products with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10023123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698234",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Metallic taste. This will most often go away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10023125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10023120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is most often given as a shot into a muscle.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10023121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10023126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10023127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11127 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-EFD95E538C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33012=[""].join("\n");
var outline_f32_15_33012=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F184543\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F184544\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023116\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023118\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023117\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023122\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023123\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023125\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023120\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023121\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023126\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023127\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?20/46/21222?source=related_link\">",
"      Iron dextran: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/20/9542?source=related_link\">",
"      Iron dextran: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_15_33013="Examination of the arterial pulse";
var content_f32_15_33013=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Examination of the arterial pulse",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33013/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33013/contributors\">",
"     Kanu Chatterjee, MB, FRCP, FCCP, FACC, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33013/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33013/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33013/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33013/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/15/33013/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of the arterial pulse characteristics is an integral part of the cardiovascular examination. Carotid, radial, brachial, femoral, posterior tibial, and dorsalis pedis pulses should be routinely examined bilaterally to ascertain any differences in the pulse amplitude, contour, or upstroke. Popliteal pulses should also be examined when lower extremity arterial disease is suspected.",
"   </p>",
"   <p>",
"    The carotid pulse contour is very similar to that of the central aortic pulse; a delay in the onset of the ascending limb of the carotid pulse, compared with the central aortic pulse, is only about 20 msec. Thus, examination of the carotid pulse provides the most accurate representation of changes in the central aortic pulse. The brachial arterial pulse is examined to assess the volume and consistency of the peripheral vessels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     UNEQUAL OR DELAYED PULSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inequality in the amplitude of the peripheral pulses may result from:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obstructive arterial diseases, most commonly atherosclerosis",
"     </li>",
"     <li>",
"      Aortic dissection",
"     </li>",
"     <li>",
"      Aortic aneurysm",
"     </li>",
"     <li>",
"      Takayasu disease",
"     </li>",
"     <li>",
"      Coarctation of the aorta",
"     </li>",
"     <li>",
"      Supravalvular aortic stenosis in which the right carotid, brachial, and radial pulses are larger in amplitude and volume than those on the left side because of the preferential streaming of the jet toward the innominate artery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Simultaneous palpation of the radial and femoral pulses is important to determine if there is a delay in pulse transmission. In normal adults, the upstrokes of the radial and femoral pulses normally appear simultaneously. A delay in the onset of the femoral pulse, generally associated with a diminished amplitude, suggests coarctation of the aorta. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=see_link&amp;anchor=H11#H11\">",
"     \"Who should be evaluated for renovascular or other causes of secondary hypertension?\", section on 'Coarctation of the aorta'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PULSUS ALTERNANS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulsus alternans (also termed mechanical alternans) is a variation in pulse amplitude occurring with alternate beats due to changing systolic pressure. It is best appreciated by applying light pressure on the peripheral arterial pulse, and can be confirmed by measuring the blood pressure. When the cuff pressure is slowly released, phase I Korotkoff sounds are initially heard only during the alternate strong beats; with further release of cuff pressure, the softer sounds of the weak beat also appear. The degree of pulsus alternans can be quantitated by measuring the difference in systolic pressure between the strong and the weak beat.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Etiology of pulsus alternans",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important cause of pulsus alternans is left ventricular failure. In clinical practice, true pulsus alternans is rarely seen in the absence of significant left ventricular myocardial failure, and should prompt further investigation to determine the severity and cause of left ventricular myocardial dysfunction. Although pulsus alternans almost exclusively occurs in systolic heart failure (low left ventricular ejection fraction), it can occur rarely in diastolic heart failure (preserved ejection fraction).",
"   </p>",
"   <p>",
"    Pulsus alternans also may be evident in the following situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Left ventricular pulsus alternans without systemic arterial pulsus alternans has been observed in patients with hypertrophic cardiomyopathy and a significant rest or provocable outflow gradient [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33013/abstract/1\">",
"       1",
"      </a>",
"      ]. The mechanism remains unclear; abolition of left ventricular alternans occurs after successful myomectomy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/42/36522?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulsus alternans is rarely encountered in patients with cardiac tamponade.",
"     </li>",
"     <li>",
"      It can occur in the presence of marked tachypnea when the respiratory rate is one-half the heart rate due to an inspiratory decrease in the pulse amplitude. The pulse abnormality disappears when respiration is held transiently.",
"     </li>",
"     <li>",
"      It may be seen in patients with severe aortic regurgitation. It is however rare in the absence of left ventricular systolic dysfunction.",
"     </li>",
"     <li>",
"      Pulsus alternans is frequently precipitated by ectopic beats; apparent pulsus alternans may be observed in patients with a bigeminal rhythm. In the latter situation, the premature beats are usually out of phase with the normal beats and postectopic pauses are appreciated. Simultaneous auscultation of the sequence of the heart sounds and palpation of the arterial pulse can differentiate between true pulsus alternans and apparent pulsus alternans due to bigeminy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pulsus alternans should not be diagnosed when the cardiac rhythm is irregular. Pulsus alternans is more common with faster heart rate. Pacing induced tachycardia can precipitate sustained pulsus alternans in patients with idiopathic dilated cardiomyopathy and is associated with worse prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Mechanism of pulsus alternans",
"    </span>",
"    &nbsp;&mdash;&nbsp;The precise mechanism for pulsus alternans remains unclear; alternating preload (Frank-Starling mechanism) and incomplete relaxation have been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33013/abstract/2\">",
"     2",
"    </a>",
"    ]. Changes in afterload, which is lower before the strong beat because of the lower output during the weak beat, may also contribute.",
"   </p>",
"   <p>",
"    It also has been suggested that a change in ventricular contractility is the primary mechanism, Changes in sarcoplasmic calcium pumps with alternate strong and weak beats appear to be the mechanism for changes in contractility. In experimental animals, acute myocardial ischemia is associated with regional pulsus alternans, leading to the hypothesis that alternating potentiation and attenuation or deletion of contraction accounts for the pulse abnormality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33013/abstract/3\">",
"     3",
"    </a>",
"    ]. Thus pulsus alternans may result primarily from an alternating contractile state of the ventricle. The magnitude of the alteration of pressure and stroke volume during pulsus alternans, indices of pump function, reflects the interaction of an alternating contractile state with changes in preload and afterload.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PULSUS PARADOXUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some respiratory variation of pulse amplitude should be observed during examination of the arterial pulse. Systolic arterial pressure normally falls during inspiration, although the magnitude of decrease usually does not exceed 8 to 12 mmHg. These changes in pulse amplitude are not usually appreciated by palpation but can be established with the sphygmomanometer.",
"   </p>",
"   <p>",
"    A more marked inspiratory decrease in arterial pressure exceeding 20 mmHg is termed pulsus paradoxus. In contrast to the normal situation, this is easily detectable by palpation, although it should be evaluated with a sphygmomanometer. When the cuff pressure is slowly released, the systolic pressure at expiration is first noted. With further slow deflation of the cuff, the systolic pressure during inspiration can also be detected. The difference between the pressures during expiration and inspiration is the magnitude of pulsus paradoxus. The inspiratory decrease in systolic pressure is accentuated during very deep inspiration or Valsalva; thus, assessment of pulsus paradoxus should be made only during normal respiration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Etiology of pulsus paradoxus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulsus paradoxus is an important physical finding in cardiac tamponade. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/57/11158?source=see_link\">",
"     \"Pulsus paradoxus in pericardial disease\"",
"    </a>",
"    .) In patients with suspected cardiac tamponade, echocardiography should be performed to detect pericardial effusion and ventricular diastolic collapse; the latter is more specific and sensitive than pulsus paradoxus for the diagnosis of tamponade [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33013/abstract/4\">",
"     4",
"    </a>",
"    ]. Pulsus paradoxus may not occur despite cardiac tamponade in patients with hemodynamically significant aortic regurgitation and atrial septal defect. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19273?source=see_link\">",
"     \"Cardiac tamponade\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to tamponade, pulsus paradoxus can occur in chronic obstructive pulmonary disease, hypovolemic shock, and infrequently in constrictive pericarditis and restrictive cardiomyopathy. It is rarely observed in pulmonary embolism, pregnancy, marked obesity, and partial obstruction of the superior vena cava.",
"   </p>",
"   <p>",
"    In hypertrophic obstructive cardiomyopathy, arterial pressure occasionally rises during inspiration (reversed pulsus paradoxus); the precise mechanism for this phenomenon is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33013/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition to changes in the amplitude, configurational changes of the carotid pulse may occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mechanism of pulsus paradoxus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism for the marked inspiratory decrease in arterial pressure with pulsus paradoxus appears to be related to the inspiratory decline of left ventricular stroke volume due to an increase in right ventricular end-diastolic volume and decreased left ventricular end-diastolic volume. In cardiac tamponade, the interventricular septum shifts toward the left ventricular cavity during inspiration (reverse Bernheim phenomenon), a result of the normal increase in venous return to the right side, thereby decreasing left ventricular preload [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33013/abstract/6\">",
"     6",
"    </a>",
"    ]. An inspiratory decrease in pulmonary venous return to the left side of the heart also has been thought to contribute to decreased left ventricular preload.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PULSUS BISFERIENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal carotid arterial pulse tracing and the central aortic pulse waveform consist of an early component, the percussion wave, which results from rapid left ventricular ejection, and a second smaller peak, the tidal wave, presumed to represent a reflected wave from the periphery. The tidal wave may increase in amplitude in hypertensive patients or in those with elevated systemic vascular resistance. Radial and femoral pulse tracings demonstrate a single sharp peak in normal circumstances.",
"   </p>",
"   <p>",
"    Pulsus bisferiens is characterized by two systolic peaks of the aortic pulse during left ventricular ejection separated by a midsystolic dip. Both percussion and tidal waves are accentuated. It is difficult to establish with certainty that the two peaks are occurring in systole with simple palpation (pulsus bisferiens) versus one peak in systole and the other in diastole (dicrotic pulse).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Etiology of pulsus bisferiens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulsus bisferiens is frequently observed in patients with hemodynamically significant (but not mild) aortic regurgitation. In patients with mixed aortic stenosis and aortic regurgitation, bisferiens pulse occurs when regurgitation is the predominant lesion. The absence of pulsus bisferiens does not exclude significant aortic regurgitation.",
"   </p>",
"   <p>",
"    In most patients with hypertrophic cardiomyopathy the carotid pulse upstroke is sharp and the amplitude is normal; pulsus bisferiens is rarely palpable but often recorded. The rapid upstroke and prominent percussion wave result from rapid left ventricular ejection into the aorta during early systole. This is followed by a rapid decline as left ventricular outflow tract obstruction ensues, a result of midsystolic obstruction and partial closure of the aortic valve. The second peak is related to the tidal wave. Occasionally, a bisferiens pulse is not present in the basal state but can be precipitated by Valsalva maneuver or by inhalation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/1/33813?source=see_link\">",
"     amyl nitrite",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Pulsus bisferiens is occasionally felt in patients with a large patent ductus arteriosus or arteriovenous fistula. A bisferiens quality of the arterial pulse also is rarely noted in patients with significant mitral valve prolapse and, very rarely in normal individuals, particularly when there is a hyperdynamic circulatory state.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Mechanism of pulsus bisferiens",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of pulsus bisferiens is not clear. It appears to be related to a large, rapidly ejected left ventricular stroke volume associated with increased left ventricular and aortic",
"    <span class=\"nowrap\">",
"     dp/dt.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DICROTIC PULSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A",
"    dicrotic pulse results from the accentuated diastolic dicrotic wave that follows the dicrotic notch. It tends to occur when the dicrotic notch is low, as in patients with decreased systemic arterial pressure and vascular resistance (eg, fever). A dicrotic pulse also may be present in patients with severe heart failure, hypovolemic shock, cardiac tamponade, conditions associated with a decreased stroke volume and elevated systemic vascular resistance, and during the immediate postoperative period following aortic valve replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33013/abstract/7\">",
"     7",
"    </a>",
"    ]. The precise mechanism for a dicrotic pulse in the last group is not clear; it is more frequently observed in patients with pump failure postoperatively. Dicrotic pulse is occasionally noted in normal individuals, particularly after exercise.",
"   </p>",
"   <p>",
"    A dicrotic pulse is frequently confused with pulsus bisferiens at the bedside; it is almost impossible to distinguish between these two types of pulse configurations without a pulse recording. Thus, the potential exists for mistaken diagnosis of aortic regurgitation due to malfunction of a prosthetic valve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     WATER HAMMER PULSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The water hammer or Corrigan (or hyperkinetic) pulse is characterized by an abrupt, very rapid upstroke of the peripheral pulse (percussion wave), followed by rapid collapse. It is best appreciated by raising the arm abruptly and feeling for the characteristics in the radial pulse.",
"   </p>",
"   <p>",
"    The water hammer pulse probably results from very rapid ejection of a large left ventricular stroke volume into a low resistance arterial system. Thus, it occurs most commonly in chronic, hemodynamically significant aortic regurgitation. A bounding arterial pulse with widened pulse pressure is not diagnostic of aortic regurgitation; it can occur in many conditions associated with increased stroke volume such as patent ductus arteriosus, large arteriovenous fistulas, hyperkinetic states, thyrotoxicosis anemia, and extreme bradycardia. The typical pulse characteristics of chronic aortic regurgitation may not occur in acute aortic regurgitation, even when it is severe, since left ventricular stroke volume may not increase appreciably, the systemic vascular resistance may not be low, and the left ventricle is not dilated.",
"   </p>",
"   <p>",
"    Other factors that can cause increased arterial pulse pressure are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/12/26823?source=see_link&amp;anchor=H4#H4\">",
"     \"Increased pulse pressure\", section on 'Factors resulting in increased pulse pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PULSES IN AORTIC STENOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Characteristic changes in the morphology of the arterial pulse may occur in the presence of fixed left ventricular outflow tract obstruction, particularly valvular aortic stenosis. Careful examination of the arterial pulse provides useful information for the diagnosis and assessment of the severity of aortic stenosis.",
"   </p>",
"   <p>",
"    Increased resistance to left ventricular ejection due to fixed obstruction reduces the stroke volume, prolongs left ventricular total ejection time, and retards the rate of initial stroke output into the aorta and distal arterial system. This results in a number of changes that can be appreciated with palpation of the carotid pulse:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anacrotic character (anacrotic pulse) &mdash; An anacrotic pulse gives the impression of interruption of the upstroke of the carotid pulse. Aortic stenosis is likely to be hemodynamically significant when the anacrotic notch is felt immediately after the onset of the upstroke. When an anacrotic notch occurs very early on the ascending limb of the arterial pulse, it can be appreciated in the radial pulse and suggests moderate to severe aortic stenosis.",
"     </li>",
"     <li>",
"      Delayed upstroke of the ascending limb (pulsus tardus) &mdash; A delayed peak and slower upstroke of the carotid pulse suggest a prolonged left ventricular ejection time. The delay can be appreciated by simultaneous palpation of the carotid pulse and auscultation of the interval between S1 and S2 (duration of systole). Normally the peak of the carotid pulse occurs closer to S1; in the presence of severe aortic stenosis, it is usually closer to S2. In the presence of fixed outflow obstruction, the central aortic pulse demonstrates a progressively slower rise of the ascending limb, a lower anacrotic shoulder, and a peak closer to the incisura as the severity of obstruction increases.",
"     </li>",
"     <li>",
"      Delayed peak",
"     </li>",
"     <li>",
"      Small amplitude (pulsus parvus) &mdash; The amplitude of the pulse decreases with a diminished stroke volume.",
"     </li>",
"     <li>",
"      Shudder (thrill) on the ascending limb &mdash; A thrill (carotid shudder) also is frequently palpable on the ascending limb of the pulse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis and severity of aortic stenosis should not be determined by changes in the carotid pulse configuration alone. The auscultatory findings of aortic stenosis and evidence for left ventricular hypertrophy should be sought.",
"   </p>",
"   <p>",
"    The carotid arteries may become rigid and less compliant in elderly patients due to arteriosclerosis. The usual changes in the carotid pulse due to aortic stenosis are modified in this situation, particularly the amplitude, which may not decrease even in the presence of severe aortic stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/43/41649?source=see_link\">",
"       \"Patient information: Aortic coarctation in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32480750\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulsus alternans is characterized by alternating amplitude of the arterial pulse. It is most commonly a sign of heart failure due to left ventricular systolic dysfunction. It can occur rarely with diastolic heart failure, cardiac tamponade, or with marked tachypnea when the respiratory rate is one-half of the heart rate. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology of pulsus alternans'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulsus paradoxus is characterized by a greater than 20 mmHg decrease in systolic arterial pressure during inspiration. Palpable pulsus paradoxus most commonly indicates impending tamponade. Other causes include chronic obstructive pulmonary disease and hypovolemic shock. Pulsus paradoxus occurs infrequently with constrictive pericarditis or restrictive cardiomyopathy, and rarely with pulmonary embolism, marked obesity, pregnancy, or partial obstruction of the superior vena cava. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Etiology of pulsus paradoxus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulsus bisferiens is characterized by two systolic peaks of the aortic pulse during left ventricular ejection separated by a midsystolic dip. Palpable pulsus bisferiens usually indicates hemodynamically significant aortic regurgitation. Less common causes include hypertrophic cardiomyopathy, large patent ductus arteriosus, arteriovenous fistula, significant mitral valve prolapse, or hyperdynamic circulatory state. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Etiology of pulsus bisferiens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An anacrotic pulse is characterized by an interruption (transient drop in amplitude) in the upstroke. An anacrotic radial pulse along with a slow rising low amplitude delayed peaking carotid pulse indicates hemodynamically significant aortic stenosis. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Pulses in aortic stenosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33013/abstract/1\">",
"      McGaughey MD, Maughan WL, Sunagawa K, Sagawa K. Alternating contractility in pulsus alternans studied in the isolated canine heart. Circulation 1985; 71:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33013/abstract/2\">",
"      GLEASON WL, BRAUNWALD E. Studies on Starling's law of the heart. VI. Relationships between left ventricular enddiatolic volume and stroke volume in man with observations on the mechanism of pulsus alternans. Circulation 1962; 25:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33013/abstract/3\">",
"      Parmley WW, Tomoda H, Fujimura S, Matloff JM. Relation between pulsus alternans and transient occlusion of the left anterior descending coronary artery. Cardiovasc Res 1972; 6:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33013/abstract/4\">",
"      Singh S, Wann LS, Klopfenstein HS, et al. Usefulness of right ventricular diastolic collapse in diagnosing cardiac tamponade and comparison to pulsus paradoxus. Am J Cardiol 1986; 57:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33013/abstract/5\">",
"      Massumi RA, Mason DT, Vera Z, et al. Reversed pulsus paradoxus. N Engl J Med 1973; 289:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33013/abstract/6\">",
"      DORNHORST AC, HOWARD P, LEATHART GL. Pulsus paradoxus. Lancet 1952; 1:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33013/abstract/7\">",
"      Orchard RC, Craige E. Dicrotic pulse after open heart surgery. Circulation 1980; 62:1107.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1077 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-217.117.136.88-94DAD92080-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33013=[""].join("\n");
var outline_f32_15_33013=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32480750\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      UNEQUAL OR DELAYED PULSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PULSUS ALTERNANS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Etiology of pulsus alternans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Mechanism of pulsus alternans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PULSUS PARADOXUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Etiology of pulsus paradoxus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mechanism of pulsus paradoxus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PULSUS BISFERIENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Etiology of pulsus bisferiens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Mechanism of pulsus bisferiens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DICROTIC PULSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      WATER HAMMER PULSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PULSES IN AORTIC STENOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32480750\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19273?source=related_link\">",
"      Cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/12/26823?source=related_link\">",
"      Increased pulse pressure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/43/41649?source=related_link\">",
"      Patient information: Aortic coarctation in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/57/11158?source=related_link\">",
"      Pulsus paradoxus in pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=related_link\">",
"      Who should be evaluated for renovascular or other causes of secondary hypertension?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_15_33014="Pediculosis corporis 2";
var content_f32_15_33014=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pediculosis corporis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 399px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This patient presented with widespread hyperpigmentation, lichenification and excoriations, most severe on his legs. His socks were covered with numerous nits and adult and immature lice.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Chris Ha, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33014=[""].join("\n");
var outline_f32_15_33014=null;
var title_f32_15_33015="Treatment and prevention of Legionella infection";
var content_f32_15_33015=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and prevention of Legionella infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33015/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33015/contributors\">",
"     M Luisa Pedro-Botet, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33015/contributors\">",
"     Victor L Yu, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33015/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33015/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33015/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33015/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/15/33015/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality of community-acquired Legionnaires' disease ranges from 16 to 30 percent if untreated or treated with inactive antibiotics; the mortality for nosocomial Legionnaires' disease can approach 50 percent given the underlying illness of the patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/1\">",
"     1",
"    </a>",
"    ]. With the advent of improved diagnostic methods leading to earlier diagnosis and more potent therapies, mortality has been reduced to less than 10 percent in patients with community-acquired legionellosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of Legionella infection will be reviewed here. The epidemiology, pathogenesis, clinical manifestations, and diagnosis of this entity are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/58/32680?source=see_link\">",
"     \"Epidemiology and pathogenesis of Legionella infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38199?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Legionella infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SUSCEPTIBILITY TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;In vitro susceptibility results are not readily interpretable for Legionella since methods have not been standardized. Conventional in vitro susceptibility methods in broth and agar have proven unreliable. For example, the charcoal in buffered charcoal yeast extract agar used for Legionella isolation binds antibiotics, and thus, activity of these antibiotics against the organism is falsely minimized. Also, many commercially available antibiotics, which have excellent in vitro activity against Legionella by conventional testing (eg, beta-lactam agents and aminoglycosides), have proven to be relatively ineffective in patients with Legionnaires' disease.",
"   </p>",
"   <p>",
"    The intracellular location of the pathogen is relevant to the efficacy of the antibiotic. Antibiotics capable of achieving intracellular concentrations higher than the minimum inhibitory concentration (MIC) are more effective clinically than antibiotics with poor intracellular penetration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/6\">",
"     6",
"    </a>",
"    ]. Antibiotics with intracellular penetration include the macrolides, quinolones, tetracyclines, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The empiric finding that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    appeared to be more effective than beta-lactam agents and aminoglycosides in early outbreaks of Legionnaires' disease was consistent with in vitro results in intracellular [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/7-11\">",
"     7-11",
"    </a>",
"    ] and animal models of Legionnaires' disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. Determination of the susceptibility of Legionella spp to antimicrobial agents is now based upon such intracellular and animal models of Legionella infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/6,15\">",
"     6,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SELECTION OF ANTIMICROBIAL AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comparative antibiotic trials have established that the newer macrolides (especially",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/16-18\">",
"     16-18",
"    </a>",
"    ] and the respiratory tract quinolones (especially",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/12,19\">",
"     12,19",
"    </a>",
"    ] are effective for Legionella infection. The newer macrolides and quinolones are superior to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      More potent intracellular activity",
"     </li>",
"     <li>",
"      Superior penetration into lung tissue, alveolar macrophages, and white blood cells",
"     </li>",
"     <li>",
"      Improved pharmacokinetic properties, which allow once or twice daily dosing",
"     </li>",
"     <li>",
"      Significantly reduced gastrointestinal toxicity compared with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other drugs that have been used successfully include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/7/40053?source=see_link\">",
"     tigecycline",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/20\">",
"     20",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    .",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     Clindamycin",
"    </a>",
"    and imipenem have been effective in a few cases but are not preferred choices (",
"    <a class=\"graphic graphic_table graphicRef65315 \" href=\"mobipreview.htm?16/14/16620\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With newer, more potent antibiotics, Legionnaires' disease can now be treated with monotherapy with one of the newer macrolides or quinolones.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Quinolones versus macrolides",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized, controlled trials comparing fluoroquinolones and macrolides. In four studies that included a total of nearly 600 patients with Legionnaires' disease, outcomes were similar in patients who received quinolones (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/60/35776?source=see_link\">",
"     ofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    ) compared with those who received macrolides (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/57/10138?source=see_link\">",
"     clarithromycin",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/4,5,21,22\">",
"     4,5,21,22",
"    </a>",
"    ]. However, more rapid defervescence, fewer complications",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    shorter hospital stay were seen with the quinolones.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Monotherapy versus combination therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anecdotal cases and selected laboratory studies have suggested possible benefit with combination therapy of a quinolone plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    or a quinolone plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. However, observational studies of antibiotic therapies for Legionnaires' disease have not validated this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Oral versus parenteral and duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although oral therapy has proven effective in cases of Legionnaires' disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/26\">",
"     26",
"    </a>",
"    ], we recommend that antibiotics be given parenterally initially to remove the possibility of incomplete gastrointestinal absorption, given the prominent gastrointestinal manifestations in some patients. When an objective clinical response can be documented (eg, defervescence), treatment can be concluded with oral agents.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     Levofloxacin",
"    </a>",
"    (500 mg once daily for 10 to 14 days or 750 mg once daily for five days) was effective in treating both mild to moderate and severe Legionella infection documented in 71 patients in six trials of community-acquired pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/27\">",
"     27",
"    </a>",
"    ]. When levofloxacin is used, we prefer to give 750 mg once daily for 7 to 10 days. When",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    is used, we favor an initial dose of 1 gram on day one, followed by 500 mg daily, with a total duration of therapy of 7 to 10 days. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/30/1514?source=see_link\">",
"     \"Azithromycin, clarithromycin, and telithromycin\"",
"    </a>",
"    .).&nbsp;",
"   </p>",
"   <p>",
"    For immunosuppressed patients who are severely ill upon presentation, a 21 day course of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    (750 mg once daily) is often recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Empiric therapy for community-acquired pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;If rapid diagnostic tests for Legionella (urinary antigen or direct fluorescent antibody) are positive, specific antibiotic therapy can be used at the outset. However, clinical signs of pneumonia will precede definitive laboratory diagnosis of Legionella in most patients, necessitating empiric coverage for many microorganisms, including Legionella. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38199?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Legionella infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The broad spectrum of the newer macrolides and the respiratory tract quinolones (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/60/12231?source=see_link\">",
"     gemifloxacin",
"    </a>",
"    ) usually provide coverage against the other common pathogens of community-acquired pneumonia (CAP) including both typical pathogens (eg, Streptococcus pneumoniae) and \"atypical\" pathogens (eg, Mycoplasma pneumoniae, Chlamydia pneumoniae). The choice of empiric therapy and the clinical importance of empiric coverage of atypical pathogens are described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/24/24969?source=see_link\">",
"     \"Treatment of community-acquired pneumonia in adults in the outpatient setting\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/1/40986?source=see_link\">",
"     \"Treatment of community-acquired pneumonia in adults who require hospitalization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Nosocomial pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;For nosocomial pneumonias and pneumonias acquired in an institution, such as a nursing home, in which Legionella is a potential pathogen, a quinolone, especially",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    , may be the empiric drug of choice. The quinolones also provide coverage against the gram-negative bacilli, which are more common pathogens in these settings than in the community.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Transplant recipients",
"    </span>",
"    &nbsp;&mdash;&nbsp;In transplant recipients with Legionella infection, we recommend treatment with a quinolone, especially",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    . The macrolides interact with the immunosuppressive agents",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    that are commonly used in transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Endocarditis and extrapulmonary legionellosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with endocarditis caused by Legionella, we recommend that combination therapy of a quinolone plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    be considered. The optimal duration of therapy is unknown, but we would administer at least three months of therapy if the infected valve is resected and three to six months if the valve is not resected.",
"   </p>",
"   <p>",
"    For patients with other forms of extrapulmonary disease (eg, skin and soft tissue infections, septic arthritis etc), the source and portal of entry needs to be delineated. In general, we would recommend a newer macrolide or quinolone for 14 to 21 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Legionnaires' disease is uncommon in AIDS patients, but, when it occurs, extrapulmonary complications and mortality are relatively high. Cavitary pneumonia and persistent bacteremia have been observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. Relapse is also more common. Thus, we recommend continuing oral maintenance antibiotic therapy for several weeks until infiltrates resolve on chest radiography. Quinolones may be preferred because of potential interaction of macrolides with some antiretroviral drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pontiac fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;This febrile, self-limited form of Legionella infection requires only symptomatic therapy, such as analgesics for headache. Antibiotics are not indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Approach to therapy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Suspected or proven Legionella pneumonia should be treated in most patients with a quinolone (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      ) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      . Patients from long-term care facilities, those with nosocomial infection, and those who have received transplants should be treated with a fluoroquinolone to provide better coverage of other gram-negative bacilli and, in the case of transplant recipients, to avoid interactions between macrolides and immunosuppressive drugs.",
"     </li>",
"     <li>",
"      We recommend parenteral treatment initially for all patients with suspected Legionella pneumonia, given gastrointestinal dysfunction in some patients. A switch to oral therapy can be made after the patient defervesces.",
"     </li>",
"     <li>",
"      The total duration of therapy for Legionella pneumonia is 7 to 10 days for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      and quinolones. A longer course of quinolones of 21 days might be considered for immunosuppressed patients who are severely ill upon presentation.",
"     </li>",
"     <li>",
"      Combination antibiotic therapy of a quinolone plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      might be considered for severely ill patients with extrapulmonary legionellosis. We also use",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      as part of combination therapy with quinolones in selected patients, but drug interactions can be problematic.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Legionella infection usually defervesce and experience symptomatic improvement within three to five days if treated early with an active antibiotic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/3\">",
"     3",
"    </a>",
"    ]. The chest radiograph is not useful for monitoring the clinical response. With early initiation of appropriate antibiotic therapy, the mortality of Legionnaires' disease is now &le;5 percent in immunocompetent patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/3,5\">",
"     3,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognosis is dependent upon expeditious administration of antibiotics. Delay in initiating appropriate antibiotics is associated with a poorer prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Failures tend to occur in patients with immunosuppressive illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/33\">",
"     33",
"    </a>",
"    ], or in patients who present with severe Legionnaires' disease at the onset of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Despite widespread use, in vitro resistance to either macrolides or quinolones has not been documented, even in those patients whose infection persisted on antibiotic therapy.",
"   </p>",
"   <p>",
"    In a follow-up, uncontrolled study of 122 survivors of a community-acquired outbreak of Legionnaires' disease, impairment of health-related quality of life was found in most patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/36\">",
"     36",
"    </a>",
"    ]. At 17 months follow-up, fatigue (75 percent) and neurologic symptoms (66 percent) were the most common persisting symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Nosocomial disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Legionnaires' disease is not transmitted from person-to-person; thus, isolation for hospitalized patients is unnecessary. Since the source of the organism is the hospital drinking water, prevention of nosocomial legionellosis is possible. Routine culturing of the hospital drinking water should be performed regardless of whether or not cases of Legionnaires' disease have been diagnosed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/37\">",
"     37",
"    </a>",
"    ]. Discovery of Legionella colonizing the water supply would then lead to the following proactive approaches:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Introduction of Legionella sputum culture methodology and urinary antigen testing for Legionella in the microbiology laboratory of a colonized hospital. Cases of Legionnaires' disease are easily overlooked if Legionella microbiology testing is not available [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An increased index of suspicion by clinicians in that hospital for the diagnosis and, thus, increased orders for the specialized laboratory tests for Legionella in patients with nosocomial pneumonia.",
"     </li>",
"     <li>",
"      Institution of empiric therapy for nosocomial legionellosis if no etiologic agent can be identified in a case of nosocomial pneumonia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Authorities from the United States Centers for Disease Control and Prevention (CDC) do not favor such an approach at this time. Instead, they advocate intense laboratory surveillance of all patients with nosocomial pneumonia for Legionnaires' disease. Environmental cultures are recommended only if one or two cases are discovered. However, this CDC recommendation has been widely ignored. In the National Nosocomial Infections Surveillance Survey (NNIS), only seven percent of 192 hospitals routinely tested all clinical sputum specimens for Legionella [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are several other drawbacks to the CDC approach. The first is that all the Legionella cultures and urinary antigen tests will be negative if the water supply is free of Legionella. In four controlled studies, nosocomial Legionnaires' disease did not occur if Legionella was absent from the water supply [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/37,39-41\">",
"     37,39-41",
"    </a>",
"    ]. The second drawback is that a Legionella outbreak in a hospital must occur before the likely source can be investigated. In our opinion, prevention is a more attractive option given the high mortality if inadequate therapy is administered.",
"   </p>",
"   <p>",
"    Guidelines for routine environmental sampling for Legionella in hospitals have now been adopted in several states in the United States, by the United States Veterans Affairs Healthcare System, and by many European countries. The CDC has accepted the concept of routine environmental culturing for institutions with bone marrow transplant programs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Disinfection of the water supply",
"    </span>",
"    &nbsp;&mdash;&nbsp;Copper-silver ionization units are the current disinfection modality of choice. There have been more than 300 installations worldwide, mostly in the United States and Spain. The first 16 installations in the United States are still operational 5 to 11 years later. Seventy-five percent of these hospitals had installed copper-silver ionization systems because of failure with other methods, notably hyperchlorination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An alternative method is to superheat and flush; in this method, the hot water temperature is raised to 70&ordm;C (158&ordm;F) and distal outlets are flushed with hot water for 30 minutes. This method can be used as an emergency measure in an outbreak [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chlorine dioxide is a promising modality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. A drawback may be the time required to eradicate Legionella from the water.",
"   </p>",
"   <p>",
"    Hyperchlorination is now obsolete, given its marginal efficacy, high cost, corrosion of piping systems, and concern about its association with spontaneous abortions and carcinogenicity of chlorine byproducts.",
"   </p>",
"   <p>",
"    The most important preventive measure for hospital-acquired Legionnaires&rsquo; disease is routine environmental cultures plus measurement of disinfection levels (chlorine dioxide or copper-silver).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Community-acquired disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monochloramine disinfection of municipal water supplies is associated with decreased risk of Legionella infection. Switching from chlorine to monochloramine for water disinfection reduced Legionella colonization in the municipality in which this conversion occurred [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33015/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21954908\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The newer macrolides (especially",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      ) and the respiratory tract quinolones (especially",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      ) are effective for Legionella infection. In four studies that included a total of nearly 600 patients with Legionnaires' disease, outcomes were similar in patients who received quinolones (levofloxacin,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/60/35776?source=see_link\">",
"       ofloxacin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      ) compared with those who received macrolides (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/57/10138?source=see_link\">",
"       clarithromycin",
"      </a>",
"      ). However, more rapid defervescence, fewer complications,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      shorter hospital stay were seen with the quinolones. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Selection of antimicrobial agents'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Quinolones versus macrolides'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Suspected or proven Legionella pneumonia should be treated in most patients with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      (750 mg once daily) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      (1 gram on day one, followed by 500 mg once daily). Patients from long-term care facilities, those with nosocomial infection, and those who have received transplants should be treated with a fluoroquinolone to provide better coverage of other gram-negative bacilli and, in the case of transplant recipients and HIV patients, to avoid interactions between macrolides and immunosuppressive drugs. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Approach to therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend parenteral treatment initially for all patients with suspected Legionella pneumonia, given gastrointestinal dysfunction in some patients. A switch to oral therapy can be made after the patient defervesces. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Approach to therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The total duration of therapy for Legionella pneumonia is 7 to 10 days. A longer course of antibiotics of 21 days might be considered for immunosuppressed patients who are severely ill upon presentation. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Approach to therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Combination antibiotic therapy of a quinolone plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      might be considered for severely ill patients with extrapulmonary legionellosis. We also use",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      as part of combination therapy with quinolones in selected patients, but drug interactions can be problematic. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Approach to therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Legionnaires' disease is not transmitted from person-to-person; thus, isolation for hospitalized patients is unnecessary. Since the source of the organism is the hospital drinking water, prevention of nosocomial legionellosis is possible by routine culturing of the hospital drinking water. Monochloramine disinfection of municipal water supplies is associated with decreased risk of Legionella infection in the community. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/1\">",
"      Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 1977; 297:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/2\">",
"      Benin AL, Benson RF, Besser RE. Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis 2002; 35:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/3\">",
"      Fern&aacute;ndez JA, L&oacute;pez P, Orozco D, Merino J. Clinical study of an outbreak of Legionnaire's disease in Alcoy, Southeastern Spain. Eur J Clin Microbiol Infect Dis 2002; 21:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/4\">",
"      Bl&aacute;zquez Garrido RM, Espinosa Parra FJ, Alemany Franc&eacute;s L, et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis 2005; 40:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/5\">",
"      Mykietiuk A, Carratal&agrave; J, Fern&aacute;ndez-Sab&eacute; N, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis 2005; 40:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/6\">",
"      Edelstein PH. Antimicrobial chemotherapy for legionnaires' disease: a review. Clin Infect Dis 1995; 21 Suppl 3:S265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/7\">",
"      Takemura H, Yamamoto H, Kunishima H, et al. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila. J Antimicrob Chemother 2000; 46:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/8\">",
"      Stout JE, Arnold B, Yu VL. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells. Diagn Microbiol Infect Dis 1998; 30:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/9\">",
"      Stout JE, Arnold B, Yu VL. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells. J Antimicrob Chemother 1998; 41:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/10\">",
"      Baltch AL, Smith RP, Franke MA, Michelsen PB. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila. Antimicrob Agents Chemother 1998; 42:3153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/11\">",
"      G&oacute;mez-Lus R, Adri&aacute;n F, del Campo R, et al. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp. Int J Antimicrob Agents 2001; 18:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/12\">",
"      Edelstein PH, Edelstein MA, Lehr KH, Ren J. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. J Antimicrob Chemother 1996; 37:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/13\">",
"      Edelstein PH, Shinzato T, Doyle E, Edelstein MA. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Antimicrob Agents Chemother 2001; 45:2204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/14\">",
"      Fraser DW, Wachsmuth I, Bopp C, et al. Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease. Lancet 1978; 1:175.",
"     </a>",
"    </li>",
"    <li>",
"     Sabria, M, Yu, VL. Legionella pneumophila. In: Antimicrobial Therapy and Vaccines, Yu, VL, Weber, R, Raoult, D (Eds), Apple Trees Productions, New York 2002. p. 395.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/16\">",
"      Miller AC. Erythromycin in legionnaires' disease: a re-appraisal. J Antimicrob Chemother 1981; 7:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/17\">",
"      Vergis EN, Indorf A, File TM Jr, et al. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med 2000; 160:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/18\">",
"      Genn&eacute; D, Siegrist HH, Humair L, et al. Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 1997; 16:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/19\">",
"      File TM Jr, Segreti J, Dunbar L, et al. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agents Chemother 1997; 41:1965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/20\">",
"      Tanaseanu C, Bergallo C, Teglia O, et al. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia. Diagn Microbiol Infect Dis 2008; 61:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/21\">",
"      Sabri&agrave; M, Pedro-Botet ML, G&oacute;mez J, et al. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest 2005; 128:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/22\">",
"      Haranaga S, Tateyama M, Higa F, et al. Intravenous ciprofloxacin versus erythromycin in the treatment of Legionella pneumonia. Intern Med 2007; 46:353.",
"     </a>",
"    </li>",
"    <li>",
"     Chidiac, C, Pires-Croneberger, S, Brun-Buisson, C, et al. Antibiotic therapy for Legionnaires' disease: results of a French study in 595 hospital patients. #L-915 (abstract) In: ICAAC/IDSA Annual Meeting, Washington, D.C., October 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/24\">",
"      Pedro-Botet ML, Garc&iacute;a-Cruz A, Tural C, et al. Severe Legionnaires' disease successfully treated with levofloxacin and azithromycin. J Chemother 2006; 18:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/25\">",
"      Pedro-Botet ML, Yu VL. Treatment strategies for Legionella infection. Expert Opin Pharmacother 2009; 10:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/26\">",
"      Kuzman I, Soldo I, Sch&ouml;nwald S, Culig J. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. Scand J Infect Dis 1995; 27:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/27\">",
"      Yu VL, Greenberg RN, Zadeikis N, et al. Levofloxacin efficacy in the treatment of community-acquired legionellosis. Chest 2004; 125:2135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/28\">",
"      Morley JN, Smith LC, Baltch AL, Smith RP. Recurrent infection due to Legionella pneumophila in a patient with AIDS. Clin Infect Dis 1994; 19:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/29\">",
"      Blatt SP, Dolan MJ, Hendrix CW, Melcher GP. Legionnaires' disease in human immunodeficiency virus-infected patients: eight cases and review. Clin Infect Dis 1994; 18:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/30\">",
"      Pedro-Botet ML, Sabri&agrave; M, Sopena N, et al. Legionnaires disease and HIV infection. Chest 2003; 124:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/31\">",
"      Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis 1996; 15:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/32\">",
"      Gacouin A, Le Tulzo Y, Lavoue S, et al. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med 2002; 28:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/33\">",
"      Pedro-Botet ML, Sabria-Leal M, Sopena N, et al. Role of immunosuppression in the evolution of Legionnaires' disease. Clin Infect Dis 1998; 26:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/34\">",
"      Matute AJ, Schurink CA, Hoepelman IM. Is a 5 day course of azithromycin enough for infections caused by Legionella pneumophila? J Antimicrob Chemother 2000; 45:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/35\">",
"      Tan JS, File TM Jr, DiPersio JR, et al. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila. Clin Infect Dis 2001; 32:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/36\">",
"      Lettinga KD, Verbon A, Nieuwkerk PT, et al. Health-related quality of life and posttraumatic stress disorder among survivors of an outbreak of Legionnaires disease. Clin Infect Dis 2002; 35:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/37\">",
"      Stout JE, Muder RR, Mietzner S, et al. Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations. Infect Control Hosp Epidemiol 2007; 28:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/38\">",
"      Fiore AE, Butler JC, Emori TG, Gaynes RP. A survey of methods used to detect nosocomial legionellosis among participants in the National Nosocomial Infections Surveillance System. Infect Control Hosp Epidemiol 1999; 20:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/39\">",
"      Johnson JT, Yu VL, Best MG, et al. Nosocomial legionellosis in surgical patients with head-and-neck cancer: implications for epidemiological reservoir and mode of transmission. Lancet 1985; 2:298.",
"     </a>",
"    </li>",
"    <li>",
"     Joly, J, Alary, M. Occurrence of nosocomial Legionnaires' disease in hospitals with contaminated potable water supply. In: Current Status and Emerging Perspectives. Barbaree, JD, Breiman, RF, Dufour, AP, (Eds). Am Soc Microbiol, Washington, DC 1994. p. 39.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/41\">",
"      Sabri&agrave; M, M&ograve;dol JM, Garcia-Nu&ntilde;ez M, et al. Environmental cultures and hospital-acquired Legionnaires' disease: a 5-year prospective study in 20 hospitals in Catalonia, Spain. Infect Control Hosp Epidemiol 2004; 25:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/42\">",
"      Stout JE, Yu VL. Experiences of the first 16 hospitals using copper-silver ionization for Legionella control: implications for the evaluation of other disinfection modalities. Infect Control Hosp Epidemiol 2003; 24:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/43\">",
"      Lin YE, Stout JE, Yu VL. Controlling Legionella in hospital drinking water: an evidence-based review of disinfection methods. Infect Control Hosp Epidemiol 2011; 32:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/44\">",
"      Srinivasan A, Bova G, Ross T, et al. A 17-month evaluation of a chlorine dioxide water treatment system to control Legionella species in a hospital water supply. Infect Control Hosp Epidemiol 2003; 24:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/45\">",
"      Zhang Z, McCann C, Stout JE, et al. Safety and efficacy of chlorine dioxide for Legionella control in a hospital water system. Infect Control Hosp Epidemiol 2007; 28:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33015/abstract/46\">",
"      Flannery B, Gelling LB, Vugia DJ, et al. Reducing Legionella colonization in water systems with monochloramine. Emerg Infect Dis 2006; 12:588.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7025 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.81.197.98-F7DA7CD4CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33015=[""].join("\n");
var outline_f32_15_33015=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21954908\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SUSCEPTIBILITY TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SELECTION OF ANTIMICROBIAL AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Quinolones versus macrolides",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Monotherapy versus combination therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Oral versus parenteral and duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Empiric therapy for community-acquired pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Nosocomial pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Endocarditis and extrapulmonary legionellosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pontiac fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Approach to therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Nosocomial disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Disinfection of the water supply",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Community-acquired disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21954908\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7025\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7025|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/14/16620\" title=\"table 1\">",
"      Antibiotic rx Legionella",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/30/1514?source=related_link\">",
"      Azithromycin, clarithromycin, and telithromycin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38199?source=related_link\">",
"      Clinical manifestations and diagnosis of Legionella infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/58/32680?source=related_link\">",
"      Epidemiology and pathogenesis of Legionella infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/24/24969?source=related_link\">",
"      Treatment of community-acquired pneumonia in adults in the outpatient setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/1/40986?source=related_link\">",
"      Treatment of community-acquired pneumonia in adults who require hospitalization",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_15_33016="Negative pressure wound dressing in situ";
var content_f32_15_33016=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F63582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F63582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Negative pressure wound dressing in situ",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fischer JE, Evenson AR. Gastrointestinal-cutaneous fistulae. In: Mastery of Surgery, Fischer JE (Ed), Lippincott Williams &amp; Wilkins 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33016=[""].join("\n");
var outline_f32_15_33016=null;
var title_f32_15_33017="Prenatal ultrasound of normal fetal kidneys transverse";
var content_f32_15_33017=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F77510%7EOBGYN%2F64756%7EOBGYN%2F69784%7EOBGYN%2F77621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F77510%7EOBGYN%2F64756%7EOBGYN%2F69784%7EOBGYN%2F77621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound, transverse view, bilateral normal kidneys in the second trimester",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bilateral normal kidneys (arrows) in the second trimester on transverse view. Note that the echogenicity is similar to other abdominal tissue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tulin Ozcan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound longitudinal view, bilateral normal kidneys second trimester",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bilateral normal kidneys (arrows) in the second trimester on longitudinal view. The sonolucent center represents urine in the renal pelvis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tulin Ozcan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound longitudinal view, normal kidney with adrenal gland",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 293px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Longitudinal view of a normal kidney and adrenal gland in the third trimester.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tulin Ozcan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound bilateral renal agenesis with adrenals in the renal fossa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 308px; height: 340px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bilateral renal agenesis, adrenals in the renal fossas seen on transverse view (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tulin Ozcan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33017=[""].join("\n");
var outline_f32_15_33017=null;
var title_f32_15_33018="Invasive gastric cancer: Surgery and prognosis";
var content_f32_15_33018=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Invasive gastric cancer: Surgery and prognosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33018/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33018/contributors\">",
"     Paul F Mansfield, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33018/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33018/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33018/contributors\">",
"     David I Soybel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/15/33018/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33018/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/15/33018/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/15/33018/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Worldwide, the incidence of and mortality from gastric cancer has declined dramatically since the 1930s. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4661?source=see_link&amp;anchor=H91192772#H91192772\">",
"     \"Epidemiology of gastric cancer\", section on 'Incidence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, gastric cancer remains a lethal disease. In the United States, approximately 21,600 patients are diagnosed annually, and 10,990 are expected to die from the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/1\">",
"     1",
"    </a>",
"    ]. Global, country-specific rates of incidence and mortality are available from the World Health Organization",
"    <a class=\"external\" href=\"file://globocan.iarc.fr/\">",
"     GLOBOCAN database",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Prognosis has improved only modestly over the last two decades, attributable to advances in surgical treatment, postoperative care, and multimodality therapy. In the US, the overall five-year survival rate for all stages combined was 27 percent between 2001 and 2007, compared to 15 percent between 1975 and 1977 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/2\">",
"     2",
"    </a>",
"    ]. The high mortality rate reflects the prevalence of advanced disease at presentation and relatively aggressive biology. Early lesions are usually asymptomatic and infrequently detected outside the realm of a screening program. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An additional contributing factor to the persistently high mortality rate is the change in the distribution of cancers from the body and antrum to the proximal stomach during the past 20 years. Cancers involving the proximal stomach and esophagogastric junction (EGJ) have increased steadily at a rate exceeding that of any other cancer, except melanoma and lung cancer. Aside from a correlation with increasing obesity, the reasons for this are unclear. Proximal lesions are biologically more aggressive and have a worse prognosis, stage for stage, than do distal gastric cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/3\">",
"     3",
"    </a>",
"    ]. This suggests that their pathogenesis differs from cancers arising in other parts of the stomach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4661?source=see_link&amp;anchor=H91192772#H91192772\">",
"     \"Epidemiology of gastric cancer\", section on 'Incidence'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4661?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology of gastric cancer\", section on 'Change in histology pattern'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32250?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidemiology, pathobiology, and clinical manifestations of esophageal cancer\", section on 'Epidemiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32250?source=see_link&amp;anchor=H27#H27\">",
"     \"Epidemiology, pathobiology, and clinical manifestations of esophageal cancer\", section on 'Pathobiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The classification and management of cancers arising at the EGJ have evolved over time. In the latest edition of the TNM staging manual, tumors arising at the EGJ, or in the cardia of the stomach within 5 cm of the EGJ that extend into the EGJ or esophagus (the so-called Siewert III EGJ tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/5\">",
"     5",
"    </a>",
"    ], see below), are staged using the TNM system for esophageal rather than stomach cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/6\">",
"     6",
"    </a>",
"    ]. However, tumors within 5 cm of the EGJ that do not extend into the esophagus are still staged (and treated) as gastric cancers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/45/7898?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis and staging of esophageal cancer\", section on 'TNM staging criteria'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\", section on 'TNM staging criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will focus on issues related to surgery for cancers arising in the stomach. Surgery may be required as a component of the staging evaluation, for potentially curative treatment of localized disease, or for palliation in cases of advanced disease. Adjuvant and neoadjuvant therapy for non-cardia gastric cancers, multimodality approaches for EGJ cancers, and the management of advanced disease are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/51/39738?source=see_link\">",
"     \"Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/31/39418?source=see_link\">",
"     \"Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/10/44202?source=see_link\">",
"     \"Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/56/19333?source=see_link\">",
"     \"Local palliation for advanced gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EARLY DIAGNOSIS OF GASTRIC CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resection offers the best chance for long-term survival for patients with localized gastric cancer, particularly in combination with adjuvant or perioperative chemotherapy or chemoradiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. A major problem is the identification of patients at a time when they are potentially curable. In the United States, two-thirds of patients present with stage III or IV disease, while only 10 percent have stage I disease (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"mobipreview.htm?11/6/11374\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mass screening programs have been effective at detecting early gastric cancer in high incidence areas such as Japan where over one-half of patients have early tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/9\">",
"     9",
"    </a>",
"    ]. The relatively low incidence of gastric cancer in many other regions including the United States (",
"    <a class=\"external\" href=\"file://globocan.iarc.fr/factsheets/cancers/stomach.asp\">",
"     Globocan database for gastric cancer incidence",
"    </a>",
"    ) makes this strategy prohibitively costly and unwarranted. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Adjuvant and neoadjuvant therapy'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37033?source=see_link\">",
"     \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nevertheless, some individuals at high risk for gastric cancer may be appropriate candidates for screening. Specific risk factors for cancer of the stomach or gastroesophageal junction include a genetic predisposition (eg, hereditary nonpolyposis colorectal cancer, familial polyposis coli, and CDH-1 gene mutation (discussed in more detail elsewhere)), dietary factors, acid hyposecretory conditions, infection with Helicobacter pylori, and Barrett's esophagus. Early evaluation of symptomatic patients may increase the likelihood of finding an early tumor. In one report, early evaluation of symptomatic patients increased the proportion of patients with stage I disease from 4 to 26 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/52/6983?source=see_link\">",
"     \"Screening and prevention of gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=see_link\">",
"     \"Risk factors for gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     STAGING EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal therapy depends upon accurate staging of the extent of disease. The preoperative evaluation permits the assessment of a clinical stage, while pathologic staging depends upon the findings at subsequent surgical exploration and examination of the pathologic specimen.",
"   </p>",
"   <p>",
"    Complete clinical or preoperative staging of patients with gastric cancer includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical examination, including evaluation of appropriate nodal areas (especially left supraclavicular nodes) as well as the abdomen and rectal examination.",
"     </li>",
"     <li>",
"      Computed tomography (CT) scans of abdomen and pelvis, and for proximal lesions, CT scan of the chest. Although CT is not very accurate for assessing the depth of tumor invasion of the stomach wall or regional nodal involvement, it may detect distant nodal or visceral metastases, ascites, or carcinomatosis. Preoperative CT scans often underestimate the extent of disease, principally because of radiographically undetectable metastases involving the liver and peritoneum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link&amp;anchor=H15#H15\">",
"       \"Clinical features, diagnosis, and staging of gastric cancer\", section on 'Abdominopelvic CT scan'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endoscopic ultrasound (EUS) may provide more accurate staging evaluation of the tumor (T) and nodal (N) stage than CT and also allows for preoperative biopsies. Its principal roles are in the evaluation of a patient being considered for neoadjuvant therapy and to identify tumors that may be amenable to endoscopic mucosal resection. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37033?source=see_link\">",
"       \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4970?source=see_link\">",
"       \"Overview of endoscopic resection of gastrointestinal tumors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link\">",
"       \"Clinical features, diagnosis, and staging of gastric cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Staging laparoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staging laparoscopy, while more invasive than CT or EUS, has the advantage of directly visualizing the liver surface, peritoneum, and local lymph nodes, and permitting biopsy of any suspicious lesions. Radiographically occult metastatic disease can be identified, avoiding unnecessary exploratory laparotomy. At laparoscopy, peritoneal metastases are documented in 20 to 30 percent of Western patients with gastric cancer with a negative CT, who would have been otherwise considered potentially resectable. In addition, peritoneal cytology can be obtained during staging laparoscopy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\", section on 'Staging laparoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The selection of patients who need staging laparoscopy is controversial. Some experts suggest restricting staging laparoscopy for patients with EUS stage",
"    <span class=\"nowrap\">",
"     T3/4",
"    </span>",
"    disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/12\">",
"     12",
"    </a>",
"    ]. Guidelines from the NCCN suggest only that laparoscopy be \"considered\" for patients who appear to have locoregional disease (other than stage IV, Tis or T1a stage) after conventional radiographic and EUS staging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/13\">",
"     13",
"    </a>",
"    ]. However, we believe it can sometimes be difficult to differentiate T2 and T3 lesions on EUS; our practice is to use preoperative staging laparoscopy for any medically fit patient who appears to have more than a T1 lesion on EUS, no histologic confirmation of stage IV disease, and who would not otherwise require a palliative gastrectomy because of symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\", section on 'Staging laparoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diagnostic laparoscopy should also be undertaken in patients who are being considered for neoadjuvant therapy trials. As an example, positive peritoneal cytology in the absence of metastatic disease elsewhere identifies a group of patients who are at particularly high risk for peritoneal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/14\">",
"     14",
"    </a>",
"    ]. Opinion differs as to the optimal way to manage such patients. At some institutions (including that of the author), patients without overt intraperitoneal metastases but who have positive peritoneal washings are referred for neoadjuvant therapy (chemotherapy and chemoradiotherapy) and then restaged to determine whether they converted to negative cytology and are candidates for potentially curative surgery. While the percentage of patients who go on to resection is low, there are occasionally patients who benefit from this approach. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Neoadjuvant chemotherapy and chemoradiotherapy'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Staging system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The TNM staging system of the combined AJCC (American Joint Committee on",
"    <span class=\"nowrap\">",
"     Cancer)/UICC",
"    </span>",
"    (International Union Against Cancer) is most frequently used (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"mobipreview.htm?11/6/11374\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/6\">",
"     6",
"    </a>",
"    ]. As noted above, the most recent 2010 edition of the TNM staging system contains numerous changes compared to the 2002 classification. These are outlined elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\", section on 'Staging systems'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    From a surgical standpoint, the most notable change is that tumors arising at the EGJ, or in the cardia of the stomach within 5 cm of the EGJ that extend into the EGJ or esophagus (Siewert III), are staged as esophageal (",
"    <a class=\"graphic graphic_table graphicRef52078 \" href=\"mobipreview.htm?4/24/4494\">",
"     table 2",
"    </a>",
"    ) rather than stomach cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/6\">",
"     6",
"    </a>",
"    ]. However, tumors within 5 cm of the EGJ that do not extend into the esophagus are still staged (and treated) as gastric cancers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/51/39738?source=see_link&amp;anchor=H12477151#H12477151\">",
"     \"Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas\", section on 'Siewert classification'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/45/7898?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis and staging of esophageal cancer\", section on 'TNM staging criteria'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The marked changes in the TNM staging system have obvious implications for interpretation and comparison of outcomes from studies that use the older versus the newer staging criteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Nodal (N) status",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence and number of involved lymph nodes is one of the most important prognostic indicators. However, the inadequacy of lymphadenectomy in contemporary North American series of gastric cancer resection is notable, even among patients treated predominantly at academic institutions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/7,15,16\">",
"     7,15,16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Extent of lymph node dissection'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H17\">",
"     'Adjuvant chemoradiotherapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The optimal extent of regional node dissection during gastrectomy for gastric cancer is intensely debated. At the core of the debate is the relationship between prognosis and the number of nodes in the surgical specimen. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Extent of lymph node dissection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The number of examined nodes influences the accuracy of staging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/17\">",
"     17",
"    </a>",
"    ]. The relationship between number of nodes and outcomes was illustrated in a series of 1038 patients undergoing potentially curative resection for gastric cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/18\">",
"     18",
"    </a>",
"    ]. The location of positive nodes did not significantly affect median survival, while the number of positive lymph nodes had a profound influence on survival provided that at least 15 lymph nodes were available for analysis. The AJCC staging guidelines suggest that at least 16 regional nodes be assessed pathologically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SURGICAL TREATMENT FOR LOCALIZED DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete surgical eradication of a gastric tumor with resection of adjacent lymph nodes represents the best chance for long-term survival. Abdominal exploration with curative intent should be undertaken unless there is unequivocal evidence of disseminated disease, major vascular invasion, a neoadjuvant approach is considered, or there are medical contraindications to surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7006444\">",
"    <span class=\"h2\">",
"     Indicators of unresectability",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only widely accepted criteria of unresectability for gastric cancer are the presence of distant metastases, invasion of a major vascular structure, such as the aorta, or disease encasement or occlusion of the hepatic artery or celiac",
"    <span class=\"nowrap\">",
"     axis/proximal",
"    </span>",
"    splenic artery. Distal splenic artery involvement is not an indicator of unresectability; the vessel can be resected en bloc with a left upper quadrant exenteration: stomach, spleen and distal pancreas.",
"   </p>",
"   <p>",
"    The lymphatics around the stomach are rich, and the presence of locoregional lymph node metastases that are located geographically distant from the tumor (eg, celiac nodes with a primary tumor on the greater curvature of the stomach) should not necessarily be considered an indicator of unresectability. However:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who have bulky adenopathy fixed to the pancreatic head that might indicate the need for a Whipple procedure are at a high risk for occult metastatic disease. In these cases, it is probably best to consider staging laparoscopy or upfront chemotherapy rather than surgery initially. Performance of a Whipple for gastric cancer is an extremely rare occurrence. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Staging laparoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lymph nodes behind or inferior to the pancreas, aorto-caval region, into the mediastinum, or in the porta hepatis are typically considered outside of the surgical field and thus evidence of unresectability. These nodes would fall into areas that would be defined as third or fourth echelon nodes in the Japanese nomenclature.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Since resection of the primary lesion also offers the most effective means of symptom palliation, exploration may also be considered in patients with known metastatic disease, if the severity of symptoms so dictates. The choice of operation for gastric cancer depends upon the location of the tumor within the stomach, the clinical stage, and the histologic type. The major surgical considerations include the extent of luminal resection (total versus subtotal gastrectomy) and the extent of lymph node dissection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7006295\">",
"    <span class=\"h3\">",
"     Linitis plastica",
"    </span>",
"    &nbsp;&mdash;&nbsp;In about 5 percent of primary gastric cancers, a broad region of the gastric wall or even the entire stomach is extensively infiltrated by malignancy, resulting in a rigid thickened stomach, termed linitis plastica. The prevalence may be higher in younger individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/3,19\">",
"     3,19",
"    </a>",
"    ]. Although most commonly due to poorly differentiated (diffuse-type) infiltrating gastric cancers, this pattern can, in rare circumstances, represent metastatic spread from lobular cancer of the breast. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/26/33194?source=see_link&amp;anchor=H14#H14\">",
"     \"Pathology and molecular pathogenesis of gastric cancer\", section on 'Diffuse type cancers'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16040?source=see_link\">",
"     \"Pathology of breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Linitis plastica has an extremely poor prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/20-24\">",
"     20-24",
"    </a>",
"    ]. In one report, one-half of all patients had metastatic disease (mainly within the peritoneal cavity) at diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/24\">",
"     24",
"    </a>",
"    ]. Nodal involvement is frequent and extensive surgery may be required for complete excision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/22,25\">",
"     22,25",
"    </a>",
"    ]. However, many surgeons consider the presence of linitis plastica to be a contraindication to potentially curative resection. In a retrospective review of 87 patients, the one and seven year survival rates following gastrectomy were 50 and 8 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Total versus subtotal gastrectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrectomy is the most widely used approach for therapy of invasive gastric cancer, although superficial cancers can sometimes be treated endoscopically. Total gastrectomy (",
"    <a class=\"graphic graphic_figure graphicRef61753 \" href=\"mobipreview.htm?2/13/2261\">",
"     figure 1",
"    </a>",
"    ) is usually performed for lesions in the proximal (upper third) of the stomach, while distal subtotal gastrectomy (with resection of adjacent lymph nodes) appears to be sufficient for lesions in the distal (lower two-thirds) of the stomach. Patients with large midgastric lesions or infiltrative disease (eg, linitis plastica) may require total gastrectomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37033?source=see_link\">",
"     \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Distal tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least two trials show no added survival benefit for total compared to subtotal gastrectomy for patients with distal tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In one of these reports, 169 patients undergoing potentially curative resection for antral adenocarcinoma were randomly assigned to total or subtotal gastrectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/27\">",
"     27",
"    </a>",
"    ]. The overall complication and perioperative mortality rates were 32 and 1.3 percent, respectively with total gastrectomy, and 34 and 3.2 percent with subtotal gastrectomy, respectively. Five-year survival was similar in both groups.",
"   </p>",
"   <p>",
"    Similar results were noted in a trial of the Italian Gastrointestinal Tumor Study Group, in which the five-year survival rates were 65 and 62 percent in the subtotal and total gastrectomy groups, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/26\">",
"     26",
"    </a>",
"    ]. In most series, quality of life after subtotal gastrectomy is superior to that after a total gastrectomy, at least in the short-term [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Data on quality of life in long-term survivors of total gastrectomy, particularly those with a jejunal reservoir reconstruction, is limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Proximal and esophagogastric junction tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The issues guiding the extent of surgical resection are more complex for tumors of the proximal stomach. Tumors of the proximal stomach that do not invade the esophagogastric junction (EGJ) can be approached by either a total gastrectomy or a proximal subtotal gastrectomy. Total gastrectomy is preferred by most surgeons for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Roux-en-Y reconstruction performed during total gastrectomy is associated with an extremely low incidence of reflux esophagitis compared to the roughly one-third of patients who develop reflux esophagitis after a proximal subtotal gastrectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Proximal subtotal gastrectomy may fail to fully remove the lymph nodes along the lesser curvature. Thus, the most common site of nodal metastases may not be fully treated surgically.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Surgical management of tumors of the EGJ is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/51/39738?source=see_link&amp;anchor=H944579#H944579\">",
"     \"Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas\", section on 'Surgical management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link&amp;anchor=H7377444#H7377444\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\", section on 'Esophagogastric junction cancer resection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Extent of lymph node dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most controversial areas in the surgical management of gastric cancer is the optimal extent of lymph node dissection. Japanese surgeons routinely perform extended lymphadenectomy, a practice that some suggest at least partially accounts for the better survival rates in Asian as compared to Western series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/33\">",
"     33",
"    </a>",
"    ]. The term \"extended lymphadenectomy\" variably refers to either a D2 or a D3 lymph node dissection. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Prognosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The draining lymph node basins for the stomach have been meticulously divided into 16 stations by Japanese surgeons: stations 1 to 6 are perigastric, and the remaining 10 are located adjacent to major vessels, behind the pancreas, and along the aorta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      D1 lymphadenectomy refers to a limited dissection of only the perigastric lymph nodes.",
"     </li>",
"     <li>",
"      D2 lymphadenectomy is an extended lymph node dissection, entailing removal of nodes along the hepatic, left gastric, celiac and splenic arteries as well as those in the splenic hilum (stations 1-11).",
"     </li>",
"     <li>",
"      D3 dissection is a superextended lymphadenectomy. The term has been used by some to describe a D2 lymphadenectomy plus the removal of nodes within the porta hepatis and periaortic regions (stations 1-16), while others use the term to denote a D2 lymphadenectomy plus periaortic nodal dissection (PAND) alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/35\">",
"       35",
"      </a>",
"      ]. Most Western surgeons (and the",
"      <span class=\"nowrap\">",
"       AJCC/UICC",
"      </span>",
"      TNM staging classification [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/6\">",
"       6",
"      </a>",
"      ]) classify disease in these regions as distant metastases and do not routinely remove nodes in these areas during a potentially curative gastrectomy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The arguments in favor of extended lymphadenectomy (ie, D2 or D3 versus D1) are that removing a larger number of nodes more accurately stages disease extent and that failure to remove these nodes leaves behind disease (which would be a potentially fatal event) in as many as one-third of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. A consequence of more accurate staging is to minimize stage migration (the &ldquo;Okie phenomenon&rdquo;, as described by Will Rodgers) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. The resulting improvement in stage-specific survival may explain, in part, the better results in Asian patients.",
"   </p>",
"   <p>",
"    The influence of total lymph node count on stage-specific survival was studied in a series of 3814 patients undergoing gastrectomy for T1-3 N0-1 (classified according to the 1997 AJCC gastric cancer staging system and reported to the Surveillance, Epidemiology and End Results (SEER) database between 1973 and 2000) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/40\">",
"     40",
"    </a>",
"    ]. For every stage subgroup",
"    <span class=\"nowrap\">",
"     (T1/2N0,",
"    </span>",
"    <span class=\"nowrap\">",
"     T1/2N1,",
"    </span>",
"    T3N0, T3N1), survival was significantly better as more nodes were examined (",
"    <a class=\"graphic graphic_table graphicRef82152 \" href=\"mobipreview.htm?23/46/24300\">",
"     table 3",
"    </a>",
"    ). Although cut point analysis revealed the greatest survival difference when 10 lymph nodes were examined, there were significant survival differences for cut points up to 40 nodes examined, always in favor of a greater number of nodes in the specimen.",
"   </p>",
"   <p>",
"    There are two main arguments against the routine use of an extended lymphadenectomy: the higher associated morbidity and mortality (particularly if splenectomy is performed in order to achieve extended lymphadenectomy) and the lack of a survival benefit for extended lymphadenectomy in most large randomized trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Randomized trials and meta-analyses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although retrospective reports suggest that extended lymphadenectomy improves survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/41-43\">",
"     41-43",
"    </a>",
"    ], multiple prospective randomized trials both in Asian and Western populations have failed to show an overall survival benefit with D2 versus D1 lymphadenectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/44-46\">",
"     44-46",
"    </a>",
"    ] or with D3 compared to D2 lymphadenectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/35,47-49\">",
"     35,47-49",
"    </a>",
"    ]. The range of findings can be illustrated by the three largest trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19671355\">",
"    <span class=\"h4\">",
"     D1 versus D2 dissection",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       MRC trial",
"      </strong>",
"      &ndash; The Medical Research Council (MRC) randomly assigned 400 patients undergoing potentially curative resection to a D1 or a D2 lymphadenectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/45\">",
"       45",
"      </a>",
"      ]. Postoperative morbidity was significantly greater in the D2 group (46 versus 28 percent), as was operative mortality (13 versus 6 percent). The excess morbidity and mortality were clearly associated with the use of splenectomy and distal pancreatectomy to achieve complete node dissection. In a later follow-up, five-year survival rates were no better for patients undergoing D2 compared to D1 dissection (33 versus 35 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Dutch trial",
"      </strong>",
"      &ndash; The largest randomized trial came from the Dutch Gastric Cancer Group and compared D1 with D2 lymphadenectomy in 711 patients who were treated with curative intent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/46,51\">",
"       46,51",
"      </a>",
"      ]. This trial relied heavily upon input from a Japanese surgeon, who trained eleven Dutch surgeons in the technique of radical lymph node dissection and monitored the operative procedures. Despite these efforts to maintain quality control of the surgical procedures, both under removal and over removal of required nodal stations occurred, somewhat blurring the distinction between the groups.",
"      <br/>",
"      <br/>",
"      As was shown in the MRC trial, both postoperative morbidity (43 versus 25 percent) and mortality (10 versus 4 percent) were higher in the D2 group. Moreover, a statistically significant survival advantage in the radical dissection group was not observed, both in the initial report [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/46\">",
"       46",
"      </a>",
"      ] and with longer follow-up [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/51,52\">",
"       51,52",
"      </a>",
"      ], despite a significantly lower risk of recurrence. This was attributed to the detrimental impact of increased operative mortality in this group.",
"      <br/>",
"      <br/>",
"      The conclusion of the Dutch trial (and its accompanying editorial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/53\">",
"       53",
"      </a>",
"      ]) was that D2 lymph node dissection could not be routinely recommended.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many clinicians consider that both the Dutch and the MRC trials are flawed. The design of the Dutch trial was based upon the assumption that radical lymph node dissection would increase the survival rate from 20 to 32 percent, likely an overestimation of benefit. Furthermore, 40 percent of enrolled patients had early gastric cancer, an unexpectedly high proportion that was not anticipated when the trial was designed.",
"   </p>",
"   <p>",
"    Moreover, both the MRC and the Dutch studies were relatively underpowered for the group of patients most likely to benefit from the extended dissection. If the proportion of patients with N2 disease is approximately 30 percent, and only approximately one-fourth of these patients survive five years after a potentially curative D2 lymphadenectomy, less than 8 percent of patients benefit long-term (0.25 x 0.30). These results indicate that one additional life might be saved for every 13 patients undergoing a D2 dissection and that much larger sample sizes are needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/37\">",
"     37",
"    </a>",
"    ]. Thus, the benefit of D2 versus D1 dissection (particularly using safer spleen-preserving D2 dissection techniques) remains controversial.",
"   </p>",
"   <p>",
"    The Dutch trial has been updated with 15-year follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/52\">",
"     52",
"    </a>",
"    ]. The survival curves have continued to separate, although the difference in overall survival is still not statistically significant (22 versus 28 percent in the D1 and D2 arms, respectively, p=0.34). However, the gastric cancer-related death rate is significantly higher in the D1 arm (48 versus 37 percent) while death rates due to other causes were not different. This supports the concept that if the D2 dissection can be done with low operative mortality, similar to that of a D1 dissection (as occurs in high volume centers), there will be a positive survival impact. This mirrors the conclusion of the latest Dutch trial paper, which is that D2 dissection is recommended in patients with potentially curable gastric cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19671433\">",
"    <span class=\"h4\">",
"     D2 versus D3 dissection",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       JCOG trial 9501",
"      </strong>",
"      &ndash; The multicenter Japan Clinical Oncology Group (JCOG) study 9501 randomly assigned 523 patients to D2 versus D3 (D2 + PAND) dissection. The overall perioperative complication rate in the D3 group was significantly higher (28.1 versus 20.9 percent), although there were no differences in major complications (anastomotic leak, pancreatic fistula, abdominal abscess, pneumonia) and perioperative mortality was very low (0.8 percent) in both groups [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/47\">",
"       47",
"      </a>",
"      ]. Five-year recurrence-free (approximately 63 percent in both groups) and overall survival (70 versus 69 percent) were no better after extended lymphadenectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/35\">",
"       35",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      One of the confounding issues with the JCOG trial is that in subgroup analysis, patients with node-negative disease fared significantly better with the more aggressive D2 operation than with D1 lymphadenectomy. Conversely, patients who were node-positive fared significantly better with a D1 lymphadenectomy than with more D2aggressive surgery. The reasons for these results counterintuitive results are unclear.",
"      <br/>",
"      <br/>",
"      Nevertheless, the high survival rate in both groups is notable in view of the fact that over 60 percent of both groups had positive nodes. These data underscore the marked differences in outcome between gastric cancers arising in Western and Asian populations. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Prognosis'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Data from the JCOG trial as well as those from other groups [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/47,54\">",
"       47,54",
"      </a>",
"      ] suggest that a D2 dissection can be performed safely with a perioperative mortality rate that is under 2 percent.",
"     </li>",
"     <li>",
"      <strong>",
"       Meta-analysis",
"      </strong>",
"      &ndash; A meta-analysis of the JCOG trial and two other smaller randomized trials of D2 versus D3 (with PAND) dissection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/48,49\">",
"       48,49",
"      </a>",
"      ] concluded that resection of the paraaortic nodes was inferior to a D2 dissection in terms of safety and without any survival benefit [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/55\">",
"       55",
"      </a>",
"      ]. Thus, paraaortic lymphadenectomy should not be considered a routine practice for surgical treatment of gastric cancer.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     The importance of surgeon and institutional expertise",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first United States study to assess outcome using Japanese lymphadenectomy criteria was performed using patients in a randomized trial of adjuvant therapy and provided a sobering view of current surgical practice in patients with resectable gastric cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/56\">",
"     56",
"    </a>",
"    ]. In this randomized trial (Intergroup trial 0116) examining the utility of adjuvant chemoradiotherapy, in 556 patients with potentially resectable gastric cancer, 54 percent underwent less than a D1 lymphadenectomy, while D1 or &ge;D2 procedures were performed in 36 and 10 percent, respectively. Others have shown that fewer than one-third of American patients undergoing gastric cancer surgery had 15 or more lymph nodes",
"    <span class=\"nowrap\">",
"     removed/examined,",
"    </span>",
"    even in academic and high-volume hospitals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/57-59\">",
"     57-59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The importance of extent of lymphadenectomy on outcome was demonstrated when patients were stratified according to the Murayama Index [MI], a computer-based model that predicts the likelihood of disease in the regional nodal stations left undissected by the surgeon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Median survival had not been reached in patients with a low MI, whereas it was only 27 months for cases with MI &ge;5.",
"   </p>",
"   <p>",
"    In view of these data, we believe that aggressive nodal dissection should only be performed in selected centers where surgeons have demonstrated acceptably low operative morbidity and mortality rates. Our own experience, as well as that at Memorial Sloan Kettering and in Japan, suggests that mortality rates under 2 percent should be expected at centers with higher patient volume [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/47,54\">",
"     47,54",
"    </a>",
"    ]. Unfortunately, such surgical expertise is limited in the United States, and data from the American College of Surgeons suggest that procedure-related mortality is significantly higher in American series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An examination of mortality rates for gastrectomy in the US has demonstrated that among patients with gastric tumors who presented to more than 700 hospitals between 1982 and 1987, the average perioperative mortality rate was 7.2 percent. &nbsp;Not surprisingly, variability in perioperative mortality appears dependent upon the volume of gastrectomies at individual institutions. In one series, perioperative mortality rates ranged from 8.7 to 13 percent at very high volume (over 21 procedures per year) and very low volume hospitals (fewer than 5 procedures per year), respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/62\">",
"     62",
"    </a>",
"    ]. The adjusted odds ratio for death at the highest compared to the lowest volume institutions was 0.72 (95% CI 0.63-0.83).",
"   </p>",
"   <p>",
"    This was also shown in a more recent study conducted in the state of Texas over a three-year period (1999 to 2001) that examined gastrectomies performed at all non-federal hospitals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/63\">",
"     63",
"    </a>",
"    ]. Over 1800 resections were performed in 214 hospitals, with high volume centers performing more than 15 resections per year and low volume centers fewer than three. Hospital mortality ranged from 5.2 to 6.2 percent in the low and intermediate hospitals, respectively, and it was 1.1 percent at the high volume centers. Even with a relatively low cutoff of only 15 resections per year for high volume centers, there were only two high volume centers in the state, underscoring the need for regionalization of this specialized surgery. The impact of hospital volume on long-term disease-free or overall survival is less clear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the apparent impact of D2 lymphadenectomy on disease specific survival, most major cancer centers are performing a D2 as compared to a D1 dissection. Treatment guidelines published by the National Comprehensive Cancer Network recommend that D2 lymph node dissection is preferred over a D1 dissection. However, in view of the higher reported rates of operative mortality when this procedure has been performed in randomized trials, this recommendation this should be tempered by where and by whom the operation is being performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If there is a survival benefit to be gained by extended lymphadenectomy, it requires that there be no added operative mortality. A pancreas and spleen-preserving D2 lymphadenectomy provides superior staging information and may provide a survival benefit while avoiding its excess morbidity. Splenectomy during gastric resection for tumors not adjacent to or invading the spleen or the tail of the pancreas increases morbidity and mortality without improving survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. Thus it is not recommended unless there is direct tumor extension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ADJUVANT AND NEOADJUVANT THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;While complete resection is the single strongest predictor of long-term survival, poor results with surgery alone, especially in patients with nodal metastases, provide the rationale for adjuvant and neoadjuvant approaches using chemotherapy, radiation therapy (RT), or a combination of the two.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Adjuvant chemoradiotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of postoperative adjuvant combined modality therapy using contemporary RT techniques and leucovorin-modulated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    was shown in a United States Intergroup study (INT-0116) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/7\">",
"     7",
"    </a>",
"    ]. The details of the adjuvant regimen are provided elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Three-year overall survival and disease-free survival were significantly better for patients receiving chemoradiotherapy. These results changed the standard of care in the United States, although there has been controversy because of the inadequacy of surgical treatment. Although D2 nodal dissection was recommended, it was only performed in 10 percent of enrollees, and 54 percent did not even have",
"    <span class=\"nowrap\">",
"     clearance/examination",
"    </span>",
"    of the D1 (perigastric) nodes. This noncompliance likely contributed to inferior survival and a 64 percent relapse rate in the surgery alone arm. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Extent of lymph node dissection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Outside of the United States, chemotherapy alone (either following surgery or combined preoperative and postoperative [perioperative] administration, based upon randomized trials demonstrating a survival benefit compared to surgery alone). (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Neoadjuvant chemotherapy and chemoradiotherapy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H12\">",
"     'Extent of lymph node dissection'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link&amp;anchor=H23495743#H23495743\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\", section on 'Adjuvant chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Neoadjuvant chemotherapy and chemoradiotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of preoperative therapy are to increase the resectability rate, reduce the rate of local and distant recurrences, and ultimately improve survival. Although postoperative chemoradiotherapy is more commonly used in the US, results from several well conducted international trials have led to the adoption of perioperative (neoadjuvant plus postoperative) chemotherapy approach to treatment of potentially resectable gastric and GE junction cancer in much of Europe and other parts of the world. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link&amp;anchor=H4#H4\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\", section on 'Neoadjuvant/perioperative chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data from several uncontrolled series suggest that some patients with initially locally advanced",
"    <strong>",
"     unresectable",
"    </strong>",
"    disease may respond to chemotherapy or chemoradiotherapy sufficiently that they are able to undergo potentially curative surgery. Perioperative morbidity and mortality rates are acceptable. The risk to benefit ratio may be less favorable in obese patients and those over the age of 60 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/68\">",
"     68",
"    </a>",
"    ].=, although this has not been seen in all studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, this approach has not been widely adopted, largely due to the lack of randomized trials defining benefit, particularly relative to postoperative chemoradiotherapy. This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link&amp;anchor=H15#H15\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\", section on 'Initially locally unresectable nonmetastatic disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An increasing number of clinicians who treat gastric cancer have a bias towards neoadjuvant therapy approaches for two major reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      First, the ability to deliver adequate postoperative therapy may be compromised by complications of the surgery. As seen in the US Intergroup 0116 trial of surgery with or without chemoradiotherapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/7\">",
"       7",
"      </a>",
"      ], up to one-third of patients do not recover quickly enough to complete the full course of postoperative treatment. Similarly, in the MAGIC trial of induction chemotherapy versus surgery alone, only 66 percent of the patients who underwent surgery were able to begin postoperative chemotherapy and approximately 40 percent of patients completed all therapy (despite a permissible delay of up to 12 weeks) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link&amp;anchor=H8#H8\">",
"       \"Adjuvant and neoadjuvant treatment of gastric cancer\", section on 'MAGIC trial'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Second, some patients have aggressive disease and develop metastases within a short period of time, despite having an adequate operation. These patients do not benefit from surgery, and the delay in operative intervention with induction therapy may have permitted their identification prior to exploratory laparotomy, thus sparing them unnecessary surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted above, one clinical scenario in which a neoadjuvant approach is favored by the author is for patients who otherwise appear to have potentially resectable disease but are found to have positive peritoneal cytology at the time of staging laparoscopy (but no overt intraperitoneal metastatic deposits). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\", section on 'Staging laparoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At our institution, such patients are referred for four to six months of upfront chemotherapy, then reassessed. If there is no evidence of extragastric progression, they then receive five weeks of chemoradiotherapy followed by a five-week rest period and a formal restaging evaluation (including a repeat laparoscopy with peritoneal washings). Patients with no evidence of metastatic disease who convert to negative cytology are considered eligible for potentially curative surgery, since a small number can achieve long-term disease-specific survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/70-73\">",
"     70-73",
"    </a>",
"    ]. While relatively few patients do not progress and thus go to resection, this is still a controversial area, and others disagree with this approach.",
"   </p>",
"   <p>",
"    When feasible, patients should be enrolled on therapeutic trials evaluating the benefit of neoadjuvant or adjuvant therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prognosis after resection varies according to the pathologic extent of disease and the population studied. As noted above, Asian populations do better than Western populations. Although stage distribution accounts for some of this difference [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/74\">",
"     74",
"    </a>",
"    ], outcomes differ even when stratified by stage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/3,42,75-77\">",
"     3,42,75-77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Western populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of the available data on prognosis are derived from series that stratified outcomes according to the older 2002 TNM staging criteria (",
"    <a class=\"graphic graphic_table graphicRef77850 \" href=\"mobipreview.htm?26/24/27021\">",
"     table 4",
"    </a>",
"    ). Five-year survival rates for gastric adenocarcinoma, as reported in the population-based National Cancer Data Base [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/78\">",
"     78",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      IA &ndash; 78 percent",
"     </li>",
"     <li>",
"      IB &ndash; 58 percent",
"     </li>",
"     <li>",
"      II &ndash; 34 percent",
"     </li>",
"     <li>",
"      IIIA &ndash; 20 percent",
"     </li>",
"     <li>",
"      IIIB &ndash; 8 percent",
"     </li>",
"     <li>",
"      IV &ndash; 7 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nomograms have been developed and validated to predict disease-specific survival following complete (R0) resection, which take into account the patient's age and sex, the primary tumor site and Lauren histologic subtype (ie, diffuse, intestinal, mixed), the depth of invasion, and the number of both positive and negative resected nodes (",
"    <a class=\"graphic graphic_figure graphicRef59660 \" href=\"mobipreview.htm?32/38/33390\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/79-82\">",
"     79-82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Contemporary data on outcomes stratified according to the new 2010 TNM staging classification (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"mobipreview.htm?11/6/11374\">",
"     table 1",
"    </a>",
"    ) are limited. The observed survival rates for over 10,000 patients with surgically resected gastric adenocarcinoma reported to the population-based SEER database between 1991 and 2000 are illustrated in the figure (",
"    <a class=\"graphic graphic_figure graphicRef69815 \" href=\"mobipreview.htm?17/0/17409\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, some of the most impressive contemporary results for treatment of high-risk gastric cancer in Western populations were reported from a multicenter Italian randomized trial comparing two different adjuvant chemotherapy regimens (leucovorin-modulated 5-FU versus weekly intensive therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    , plus leucovorin-modulated 5-FU) in 400 patients with either T3 or node-positive gastric cancer (90 percent stage IIIA, IIIB, or &gt;15 involved nodes [N3], as defined by the 2002 TNM staging criteria) (",
"    <a class=\"graphic graphic_table graphicRef77850 \" href=\"mobipreview.htm?26/24/27021\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/83\">",
"     83",
"    </a>",
"    ]. While there was no evidence of a survival benefit for the more intensive chemotherapy regimen, the five-year overall survival rates in both groups were higher than expected (50 and 52 percent in both arms), despite the fact that fewer than one-half of either group completed the entire course of adjuvant therapy. Notably, approximately 80 percent of all enrolled patients underwent either a D1 or D2 lymphadenectomy, and 80 percent had more than 15 nodes examined. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Extent of lymph node dissection'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similarly, data from our own institution has shown that among patients who completed neoadjuvant chemoradiotherapy and who had a D2 lymphadenectomy at the time of resection, median survival was 7.6 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Asian populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The better outcomes seen in many (but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/85\">",
"     85",
"    </a>",
"    ]) studies of Asian populations can be illustrated by a carefully conducted randomized trial from the JCOG in which 523 patients, approximately two-thirds with node-positive (stage III) disease, were assigned to D2 versus D3 lymphadenectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/35\">",
"     35",
"    </a>",
"    ]. The overall five-year disease-free survival rates in both groups were approximately 62 percent, and the operative mortality rates in both groups were less than 1 percent. These patients were carefully selected for good overall health, and they had documented negative peritoneal cytology. Nevertheless, these are far better outcomes than would be expected in even highly selected Western populations. The study also revealed paradoxical results on subgroup analysis; patients with negative nodes did better with a more extensive operation while those with node-positive disease had a better outcome with a less extensive operation. The reasons for this are unknown.",
"   </p>",
"   <p>",
"    Other analyses have also demonstrated superior outcomes in Asian as compared to non-Asian populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several hypotheses have been put forth to explain the differences between Western and Asian patients, including stage migration, differences in treatment, and race-related differences in tumor biology, behavior, and host-tumor interactions. Treatment factors may predominate over biologic factors, as suggested by a stage-stratified comparison of outcomes after gastric cancer resection among 3176 Tokyo Japanese patients treated according to Japanese techniques and 279 Japanese immigrants to Hawaii who were treated using Western surgical techniques between 1974 and 1985 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/87\">",
"     87",
"    </a>",
"    ]. For every stage of disease (using the Western AJCC TNM staging system from 2002) (",
"    <a class=\"graphic graphic_table graphicRef77850 \" href=\"mobipreview.htm?26/24/27021\">",
"     table 4",
"    </a>",
"    ), five-year survival rates were superior for the Tokyo Japanese:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stage I &ndash; 96 versus 86 percent",
"     </li>",
"     <li>",
"      Stage II &ndash; 77 versus 69 percent",
"     </li>",
"     <li>",
"      Stage III &ndash; 49 versus 21 percent",
"     </li>",
"     <li>",
"      Stage IV &ndash; 14 versus 4 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sites of disease recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two major areas of treatment failure in patients with resected gastric carcinoma are local recurrence and distant metastases. In most series, distant failures predominate, even in patients with a positive surgical margin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/3,88,89\">",
"     3,88,89",
"    </a>",
"    ]. In data from the American College of Surgeons, recurrence following attempted curative resection was local or regional in 40 percent and systemic in 60 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/3\">",
"     3",
"    </a>",
"    ]. However, locoregional recurrences seem to be more frequent in patients treated with surgery alone or surgery plus chemotherapy, and among those who have a fewer number of negative resected lymph nodes in the operative specimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/90,91\">",
"     90,91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sites of locoregional failure include the luminal margins, the resection bed and the regional nodal basins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/18\">",
"     18",
"    </a>",
"    ]. The predominant sites of systemic recurrence are the liver and peritoneum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/92\">",
"     92",
"    </a>",
"    ]. Metastatic disease beyond the abdomen is uncommonly the first site of recurrence aside from the supraclavicular nodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     POSTTREATMENT CANCER SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials to guide the postoperative surveillance strategy. Consensus-based guidelines from the National Comprehensive Cancer Network (NCCN) suggest the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History and physical examination every three to six months for one to three years, then every six months for years four and five, then annually.",
"     </li>",
"     <li>",
"      CBC and chemistry profile, as clinically indicated",
"     </li>",
"     <li>",
"      Radiologic imaging or endoscopy, as clinically indicated",
"     </li>",
"     <li>",
"      Monitor for vitamin B12 deficiency in surgically treated patients and treat as indicated",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some clinicians check tumor markers (particularly carcinoembryonic antigen [CEA]) with each follow-up up visit, and perform restaging CT scans every three to six months, at least for the first two years, which is controversial. Although early detection can facilitate treatment before the development of symptomatic bulky disease that may be difficult to manage (eg, bowel entrapment from peritoneal disease recurrence), there are no data to support the view that early detection of an asymptomatic recurrence by tumor marker elevation or radiologic imaging improves quality of life or prolongs survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/93,94\">",
"     93,94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients who have had a subtotal gastrectomy, we perform surveillance endoscopy every 6 to 12 months for the first two years since survivors are at higher risk for a second primary gastric cancer, but these patients may likely have a lower risk of gastric cancer for many subsequent years.",
"   </p>",
"   <p>",
"    We supplement all patients who have undergone total or subtotal gastrectomy with vitamin B12 (once monthly intramuscularly or a sublingual B-complex vitamin daily) and monitor levels of both vitamin B12 and D. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/0/5130?source=see_link\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\"",
"    </a>",
"    .) We are becoming increasingly aware of the critical role vitamin D plays and the alarming frequency of low levels in patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     TREATMENT OF RECURRENT DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Curative resection is not often attempted in patients with recurrent disease, although there are a few case series that describe long-term survivors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/95-101\">",
"     95-101",
"    </a>",
"    ]. In a series of 60 patients (seen over a thirty year period) who underwent an attempted resection for recurrent gastric or gastroesophageal cancer, 29 were resectable at laparotomy, 14 of whom required adjacent organ resection, and six, interposition grafting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/95\">",
"     95",
"    </a>",
"    ]. Median overall survival for patients undergoing resection was 26 months, compared to six months for unresectable patients.",
"   </p>",
"   <p>",
"    While these results suggest that salvage surgery may contribute to prolonged survival, the opportunity to resect recurrent gastric tumors is infrequent at best. This approach should be restricted to highly selected fit patients with an isolated local recurrence and no evidence of distant spread.",
"   </p>",
"   <p>",
"    Rather than surgery, most such patients are offered systemic chemotherapy for palliation of symptoms. Occasionally, local palliative procedures, such as radiotherapy (in patients not previously having received radiotherapy at the site of recurrence), are needed for symptom control. The treatment of advanced gastric cancer is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/56/19333?source=see_link&amp;anchor=H6#H6\">",
"     \"Local palliation for advanced gastric cancer\", section on 'Radiation therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/10/44202?source=see_link\">",
"     \"Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PALLIATIVE GASTRECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with locally advanced or metastatic disease, surgical intervention may provide effective palliation of symptoms such as pain, nausea, persistent bleeding, or obstruction. However, anemia in a stable patient should not be considered an indication for a palliative gastrectomy. &nbsp;Radical gastrectomy in this setting provides no survival benefit, but palliative gastrectomy can provide symptomatic relief and a possible improvement in survival, although this is controversial. The criteria for selection of patients who may benefit from palliative gastrectomy as compared to other palliative procedures (including radiation therapy, endoscopic intervention, surgical bypass) are not firmly established. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/56/19333?source=see_link&amp;anchor=H3#H3\">",
"     \"Local palliation for advanced gastric cancer\", section on 'Palliative resection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     METASTASECTOMY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H97681124\">",
"    <span class=\"h2\">",
"     Hepatic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic metastasectomy has been performed for the rare patient with isolated gastric cancer liver metastases. The major reason this is such a rare event is that the rate of isolated liver metastases in gastric cancer is only 0.5 percent (and this amongst Asian populations) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41850?source=see_link\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite extremely stringent selection, long-term survival is extremely rare following hepatic resection of apparently isolated gastric cancer liver metastases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/15/33018/abstract/102-107\">",
"     102-107",
"    </a>",
"    ]. There is a lack of consensus as to indications for hepatectomy or appropriate patient selection criteria, but overall, it is quite unlikely that an individual patient will benefit from resection of gastric cancer liver metastases.",
"   </p>",
"   <p>",
"    Other nonsurgical methods for local tumor ablation of isolated liver metastases are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/36/28234?source=see_link\">",
"     \"Nonsurgical local treatment strategies for colorectal cancer liver metastases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H97681131\">",
"    <span class=\"h2\">",
"     Pulmonary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary metastasectomy for metastatic gastric cancer can potentially result in long-term survival in a highly selected group of patients. However, this approach should be reserved for those patients who present with small isolated lesions after a prolonged disease-free interval. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link&amp;anchor=H96886119#H96886119\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\", section on 'Gastric cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?31/28/32195?source=see_link\">",
"       \"Patient information: Stomach cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195171569\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgery may be required as a component of the staging evaluation for gastric cancer, for potentially curative treatment of localized disease, or for palliation in cases of advanced disease. Complete surgical eradication of a gastric tumor with resection of adjacent lymph nodes represents the best chance for long-term survival. Unless there is unequivocal evidence of disseminated disease, major vascular invasion, or there are other contraindications to surgery, either abdominal exploration with curative intent resection should be undertaken or a neoadjuvant approach should be considered. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of operation for gastric cancer depends upon the location of the tumor within the stomach, the clinical stage, and the histologic type. The major surgical considerations include the extent of luminal resection (total versus subtotal gastrectomy) and the extent of lymph node dissection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Total gastrectomy (",
"      <a class=\"graphic graphic_figure graphicRef61753 \" href=\"mobipreview.htm?2/13/2261\">",
"       figure 1",
"      </a>",
"      ) is usually performed for lesions in the proximal (upper third) of the stomach, while distal subtotal gastrectomy (with resection of adjacent lymph nodes) appears to be sufficient for lesions in the distal (lower two-thirds) of the stomach. Patients with large midgastric lesions or infiltrative disease (eg, linitis plastica) may require total gastrectomy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Total versus subtotal gastrectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tumors of the proximal stomach that do not invade the esophagogastric junction (EGJ) can be approached by either a total gastrectomy or a proximal subtotal gastrectomy. Total gastrectomy is preferred by most surgeons. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Proximal and esophagogastric junction tumors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical management of tumors involving the EGJ is discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/51/39738?source=see_link&amp;anchor=H944579#H944579\">",
"       \"Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas\", section on 'Surgical management'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link&amp;anchor=H7377444#H7377444\">",
"       \"Surgical oncologic principles for management of resectable esophageal cancer\", section on 'Esophagogastric junction cancer resection'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      The optimal extent of lymphadenectomy is debated. While several randomized trials have failed to show an overall survival benefit from a D2 compared to a D1 resection, excess morbidity and mortality were clearly associated with the use of splenectomy and distal pancreatectomy to achieve complete node dissection. The most recent report of the Dutch trial suggests that cancer-specific mortality rates are significantly lower in patients who undergo a D2 rather than a D1 lymphadenectomy.",
"     </li>",
"     <li>",
"      We suggest a D2 rather than a D1 resection for patients who are undergoing potentially curative resection of a gastric cancer (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). However, aggressive nodal dissection should only be performed in selected centers where surgeons have demonstrated acceptably low operative morbidity and mortality rates. Perioperative mortality rates under 2 percent should be expected at centers with higher patient volume. (See",
"      <a class=\"local\" href=\"#H19671355\">",
"       'D1 versus D2 dissection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In contrast, there is no evidence that a D3 (paraaortic lymphadenectomy) confers a survival benefit over D2 dissection, and it is associated with greater mortality. We recommend that a D3 dissection not be considered for surgical treatment of gastric cancer (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19671433\">",
"       'D2 versus D3 dissection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Data from several uncontrolled series suggest that some patients with initially locally advanced",
"      <strong>",
"       unresectable",
"      </strong>",
"      disease may respond to chemotherapy or chemoradiotherapy sufficiently that they are able to undergo potentially curative surgery. However, this approach should ideally be considered in the context of a clinical trial. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Neoadjuvant chemotherapy and chemoradiotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with locally advanced or metastatic disease, surgical intervention may provide effective palliation of symptoms such as pain, nausea, bleeding, or obstruction. The criteria for selection of patients who may benefit from palliative gastrectomy as compared to other palliative procedures (including radiation therapy, endoscopic intervention, surgical bypass) are not firmly established. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Palliative gastrectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hepatic or pulmonary metastasectomy for isolated metastatic lesions can potentially result in long-term survival in a highly selected group of patients. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Metastasectomy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/1\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/2\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/3\">",
"      Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993; 218:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/4\">",
"      Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/5\">",
"      R&uuml;diger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 232:353.",
"     </a>",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.117.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/7\">",
"      Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/8\">",
"      Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/9\">",
"      Yoshida S, Saito D. Gastric premalignancy and cancer screening in high-risk patients. Am J Gastroenterol 1996; 91:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/10\">",
"      Sue-Ling HM, Johnston D, Martin IG, et al. Gastric cancer: a curable disease in Britain. BMJ 1993; 307:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/11\">",
"      Sussman SK, Halvorsen RA Jr, Illescas FF, et al. Gastric adenocarcinoma: CT versus surgical staging. Radiology 1988; 167:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/12\">",
"      Power DG, Schattner MA, Gerdes H, et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg 2009; 208:173.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/14\">",
"      Oh CA, Bae JM, Oh SJ, et al. Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology. J Surg Oncol 2012; 105:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/15\">",
"      Wanebo HJ, Kennedy BJ, Winchester DP, et al. Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg 1996; 183:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/16\">",
"      Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 2006; 107:2143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/17\">",
"      Bouvier AM, Haas O, Piard F, et al. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer 2002; 94:2862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/18\">",
"      Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg 2000; 232:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/19\">",
"      Windham TC, Termuhlen PM, Ajani JA, Mansfield PF. Adenocarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome. J Surg Oncol 2002; 81:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/20\">",
"      Higgins GA, Serlin O, Amadeo JH, et al. Gastric cancer: factors in survival. Surg Gastrointest 1976; 10:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/21\">",
"      Henning GT, Schild SE, Stafford SL, et al. Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys 2000; 46:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/22\">",
"      Hamy A, Letessier E, Bizouarn P, et al. Study of survival and prognostic factors in patients undergoing resection for gastric linitis plastica: a review of 86 cases. Int Surg 1999; 84:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/23\">",
"      Haugstvedt TK, Viste A, Eide GE, S&ouml;reide O. Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial. Br J Surg 1993; 80:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/24\">",
"      Najam AA, Yao JC, Lenzi R, et al. Linitis plastica is common in women and in poorly differentiated and signet ring cell histologies: an analysis of 217 patients (abstract). Proc Am Soc Clin Oncol 2002; 21:166a.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/25\">",
"      Furukawa H, Hiratsuka M, Iwanaga T, et al. Extended surgery--left upper abdominal exenteration plus Appleby's method--for type 4 gastric carcinoma. Ann Surg Oncol 1997; 4:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/26\">",
"      Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999; 230:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/27\">",
"      Gouzi JL, Huguier M, Fagniez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 1989; 209:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/28\">",
"      Anderson ID, MacIntyre IM. Symptomatic outcome following resection of gastric cancer. Surg Oncol 1995; 4:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/29\">",
"      Wu CW, Chiou JM, Ko FS, et al. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 2008; 98:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/30\">",
"      Iivonen MK, Mattila JJ, Nordback IH, Matikainen MJ. Long-term follow-up of patients with jejunal pouch reconstruction after total gastrectomy. A randomized prospective study. Scand J Gastroenterol 2000; 35:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/31\">",
"      Tyrv&auml;inen T, Sand J, Sintonen H, Nordback I. Quality of life in the long-term survivors after total gastrectomy for gastric carcinoma. J Surg Oncol 2008; 97:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/32\">",
"      Buhl K, Schlag P, Herfarth C. Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol 1990; 16:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/33\">",
"      Noguchi Y, Yoshikawa T, Tsuburaya A, et al. Is gastric carcinoma different between Japan and the United States? Cancer 2000; 89:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/34\">",
"      Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/35\">",
"      Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/36\">",
"      Wagner PK, Ramaswamy A, R&uuml;schoff J, et al. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991; 78:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/37\">",
"      Roukos DH, Kappas AM. Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 2002; 81:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/38\">",
"      Bunt AM, Hermans J, Smit VT, et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995; 13:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/39\">",
"      de Manzoni G, Verlato G, Roviello F, et al. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 2002; 87:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/40\">",
"      Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005; 23:7114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/41\">",
"      Noguchi Y, Imada T, Matsumoto A, et al. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer 1989; 64:2053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/42\">",
"      Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/43\">",
"      Roder JD, B&ouml;ttcher K, Siewert JR, et al. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 1993; 72:2089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/44\">",
"      Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988; 75:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/45\">",
"      Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/46\">",
"      Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/47\">",
"      Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22:2767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/48\">",
"      Kulig J, Popiela T, Kolodziejczyk P, et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007; 193:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/49\">",
"      Yonemura Y, Wu CC, Fukushima N, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 2008; 13:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/50\">",
"      Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/51\">",
"      Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22:2069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/52\">",
"      Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/53\">",
"      Petrelli NJ. The debate is over; it's time to move on. J Clin Oncol 2004; 22:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/54\">",
"      Smith JW, Shiu MH, Kelsey L, Brennan MF. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991; 126:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/55\">",
"      Chen XZ, Hu JK, Zhou ZG, et al. Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer. J Am Coll Surg 2010; 210:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/56\">",
"      Hundahl SA, Macdonald JS, Benedetti J, et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002; 9:278.",
"     </a>",
"    </li>",
"    <li>",
"     Coburn NG, Swallow C, Quan ML, et al. Significant regional variation in treatment and survival of gastric cancer (abstract). J Clin Oncol 2005; 23:309s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/58\">",
"      Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 2005; 12:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/59\">",
"      Bilimoria KY, Talamonti MS, Wayne JD, et al. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg 2008; 143:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/60\">",
"      Kampsch&ouml;er GH, Maruyama K, van de Velde CJ, et al. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 1989; 76:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/61\">",
"      Bollschweiler E, Boettcher K, Hoelscher AH, et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program. Br J Surg 1992; 79:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/62\">",
"      Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/63\">",
"      Smith DL, Elting LS, Learn PA, et al. Factors influencing the volume-outcome relationship in gastrectomies: a population-based study. Ann Surg Oncol 2007; 14:1846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/64\">",
"      Enzinger PC, Benedetti JK, Meyerhardt JA, et al. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg 2007; 245:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/65\">",
"      Csendes A, Burdiles P, Rojas J, et al. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002; 131:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/66\">",
"      Brady MS, Rogatko A, Dent LL, Shiu MH. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 1991; 126:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/67\">",
"      Wanebo HJ, Kennedy BJ, Winchester DP, et al. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg 1997; 185:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/68\">",
"      Fujitani K, Ajani JA, Crane CH, et al. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 2007; 14:2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/69\">",
"      An JY, Kim KM, Kim YM, et al. Surgical complications in gastric cancer patients preoperatively treated with chemotherapy: their risk factors and clinical relevance. Ann Surg Oncol 2012; 19:2452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/70\">",
"      Badgwell B, Cormier JN, Krishnan S, et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008; 15:2684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/71\">",
"      Okabe H, Ueda S, Obama K, et al. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol 2009; 16:3227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/72\">",
"      Lorenzen S, Panzram B, Rosenberg R, et al. Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection. Ann Surg Oncol 2010; 17:2733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/73\">",
"      Mezhir JJ, Shah MA, Jacks LM, et al. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol 2010; 17:3173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/74\">",
"      Verdecchia A, Mariotto A, Gatta G, et al. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003; 39:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/75\">",
"      Strong VE, Song KY, Park CH, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010; 251:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/76\">",
"      Gill S, Shah A, Le N, et al. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. J Clin Oncol 2003; 21:2070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/77\">",
"      Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol 2001; 40:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/78\">",
"      Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the \"different disease\" hypothesis. Cancer 2000; 88:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/79\">",
"      Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003; 21:3647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/80\">",
"      Peeters KC, Kattan MW, Hartgrink HH, et al. Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer 2005; 103:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/81\">",
"      Novotny AR, Schuhmacher C, Busch R, et al. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg 2006; 243:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/82\">",
"      Han DS, Suh YS, Kong SH, et al. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol 2012; 30:3834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/83\">",
"      Cascinu S, Labianca R, Barone C, et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007; 99:601.",
"     </a>",
"    </li>",
"    <li>",
"     Bose, D, Baddgwell, B, Cormier, JN, et al. Association of neoadjuvant chemoradiation with improved survival in resectable gastric cancer (abstract). Data presented at the 2009 ASCO Gastrointestinal Cancers Symposium, San francisco, CA, January 15-17, 2009. Abstract available online at  file://www.asco.org/ascov2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=63&amp;abstractID=10135 (Accessed on December 02, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/85\">",
"      Lee WJ, Lee WC, Houng SJ, et al. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg 1995; 19:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/86\">",
"      Macdonald JS. Gastric cancer: Nagoya is not New York. J Clin Oncol 2011; 29:4348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/87\">",
"      Hundahl SA, Stemmermann GN, Oishi A. Racial factors cannot explain superior Japanese outcomes in stomach cancer. Arch Surg 1996; 131:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/88\">",
"      Wang SY, Yeh CN, Lee HL, et al. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol 2009; 16:2738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/89\">",
"      Nagata T, Ichikawa D, Komatsu S, et al. Prognostic impact of microscopic positive margin in gastric cancer patients. J Surg Oncol 2011; 104:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/90\">",
"      Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/91\">",
"      Li F, Zhang R, Liang H, et al. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection. J Surg Oncol 2013; 107:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/92\">",
"      Landry J, Tepper JE, Wood WC, et al. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990; 19:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/93\">",
"      Eom BW, Ryu KW, Lee JH, et al. Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer. Ann Surg Oncol 2011; 18:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/94\">",
"      Yoon SS. How closely should we follow gastric cancer patients following surgical resection? Ann Surg Oncol 2011; 18:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/95\">",
"      Badgwell B, Cormier JN, Xing Y, et al. Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol 2009; 16:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/96\">",
"      Kodera Y, Ito S, Yamamura Y, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol 2003; 10:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/97\">",
"      Miller RC, Haddock MG, Gunderson LL, et al. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus 2006; 19:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/98\">",
"      An JY, Youn HG, Ha TK, et al. Clinical significance of tumor location in remnant gastric cancers developed after partial gastrectomy for primary gastric cancer. J Gastrointest Surg 2008; 12:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/99\">",
"      Ohashi M, Katai H, Fukagawa T, et al. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg 2007; 94:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/100\">",
"      Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000; 87:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/101\">",
"      Shchepotin I, Evans SR, Shabahang M, et al. Radical treatment of locally recurrent gastric cancer. Am Surg 1995; 61:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/102\">",
"      Linhares E, Monteiro M, Kesley R, et al. Major hepatectomy for isolated metastases from gastric adenocarcinoma. HPB (Oxford) 2003; 5:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/103\">",
"      Cheon SH, Rha SY, Jeung HC, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 2008; 19:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/104\">",
"      Koga R, Yamamoto J, Ohyama S, et al. Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. Jpn J Clin Oncol 2007; 37:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/105\">",
"      Okano K, Maeba T, Ishimura K, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 2002; 235:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/106\">",
"      Shirabe K, Wakiyama S, Gion T, et al. Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature. HPB (Oxford) 2006; 8:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/15/33018/abstract/107\">",
"      Ambiru S, Miyazaki M, Ito H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg 2001; 181:279.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2481 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-3C5F28D7A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33018=[""].join("\n");
var outline_f32_15_33018=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H195171569\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EARLY DIAGNOSIS OF GASTRIC CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STAGING EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Staging laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Staging system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Nodal (N) status",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SURGICAL TREATMENT FOR LOCALIZED DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7006444\">",
"      Indicators of unresectability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7006295\">",
"      - Linitis plastica",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Total versus subtotal gastrectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Distal tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Proximal and esophagogastric junction tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Extent of lymph node dissection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Randomized trials and meta-analyses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19671355\">",
"      D1 versus D2 dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19671433\">",
"      D2 versus D3 dissection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - The importance of surgeon and institutional expertise",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ADJUVANT AND NEOADJUVANT THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Adjuvant chemoradiotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Neoadjuvant chemotherapy and chemoradiotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Western populations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Asian populations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sites of disease recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      POSTTREATMENT CANCER SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      TREATMENT OF RECURRENT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PALLIATIVE GASTRECTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      METASTASECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H97681124\">",
"      Hepatic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H97681131\">",
"      Pulmonary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H195171569\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2481\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2481|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/13/2261\" title=\"figure 1\">",
"      Total gastrectomy with reconstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/38/33390\" title=\"figure 2\">",
"      Nomogram DSS resect gastric CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/0/17409\" title=\"figure 3\">",
"      SEER survival gast CA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2481|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/6/11374\" title=\"table 1\">",
"      2010 TNM staging stomach CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/24/4494\" title=\"table 2\">",
"      TNM staging esoph adenoCA including EGJ",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/46/24300\" title=\"table 3\">",
"      Survival by number LNs examined",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/24/27021\" title=\"table 4\">",
"      2002 TNM staging stomach CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=related_link\">",
"      Adjuvant and neoadjuvant treatment of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/10/44202?source=related_link\">",
"      Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=related_link\">",
"      Clinical features, diagnosis, and staging of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/45/7898?source=related_link\">",
"      Diagnosis and staging of esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/0/5130?source=related_link\">",
"      Diagnosis and treatment of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37033?source=related_link\">",
"      Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4661?source=related_link\">",
"      Epidemiology of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32250?source=related_link\">",
"      Epidemiology, pathobiology, and clinical manifestations of esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/56/19333?source=related_link\">",
"      Local palliation for advanced gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41850?source=related_link\">",
"      Management of potentially resectable colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/51/39738?source=related_link\">",
"      Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/36/28234?source=related_link\">",
"      Nonsurgical local treatment strategies for colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4970?source=related_link\">",
"      Overview of endoscopic resection of gastrointestinal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/26/33194?source=related_link\">",
"      Pathology and molecular pathogenesis of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16040?source=related_link\">",
"      Pathology of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?31/28/32195?source=related_link\">",
"      Patient information: Stomach cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/31/39418?source=related_link\">",
"      Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=related_link\">",
"      Risk factors for gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/52/6983?source=related_link\">",
"      Screening and prevention of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=related_link\">",
"      Surgical oncologic principles for management of resectable esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=related_link\">",
"      Surgical resection of pulmonary metastases: Outcomes by histology",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_15_33019="Two hour GTT for GDM";
var content_f32_15_33019=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61208&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61208&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for a positive two hour 75 gram oral glucose tolerance test for the diagnosis of gestational diabetes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        World Health Organization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fasting",
"       </td>",
"       <td>",
"        &ge;125 mg/dL (6.9 mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two hour",
"       </td>",
"       <td>",
"        &ge;140 mg/dL (7.8 mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        International Association of Diabetes and Pregnancy Study Groups (IADPSG) and American Diabetes Association",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fasting",
"       </td>",
"       <td>",
"        &ge;92 mg/dL (5.1 mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One hour",
"       </td>",
"       <td>",
"        &ge;180 mg/dL (10.0 mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two hour",
"       </td>",
"       <td>",
"        &ge;153 mg/dL (8.5 mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        These values represent the average glucose values at which infant birth weight, cord C-peptide, and percent body fat &gt;90 percentile reached 1.75 times the estimated odds of these outcomes at mean glucose values from the HAPO study population, based on fully adjusted logistic regression models.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33019=[""].join("\n");
var outline_f32_15_33019=null;
var title_f32_15_33020="Clinical indicators of acute malignant hyperthermia";
var content_f32_15_33020=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F54539&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F54539&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical indicators of acute malignant hyperthermia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td rowspan=\"2\">",
"       <strong>",
"        Rigidity",
"       </strong>",
"      </td>",
"      <td>",
"       Generalized muscular rigidity without shivering during or following emergence from inhalational anesthesia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Masseter muscle spasm shortly following succinylcholine administration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"6\">",
"       <strong>",
"        Rhabomyolysis",
"       </strong>",
"      </td>",
"      <td>",
"       CK &gt;20,000 IU after anesthesia with succinylcholine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CK &gt;10,000 IU after anesthesia without succinylcholine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cola colored urine in perioperative period",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Urine myoglobin &gt;60 &micro;g/L",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serum myoglobin &gt;170 &micro;g/L",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serum K &gt;6meq/L (without renal failure)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"8\">",
"       <strong>",
"        Acidosis",
"       </strong>",
"      </td>",
"      <td class=\"sublist1_start\">",
"       Controlled ventilation:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       PETCO2 &gt;55",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       PaCO2 &gt;60",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Spontaneous ventilation:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       PetCO2 &gt;60",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       PaCO2 &gt;65",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inappropriate hypercarbia (judgement)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inappropriate tachypnea (judgement)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       <strong>",
"        Fever",
"       </strong>",
"      </td>",
"      <td>",
"       Inappropriate rapid increase in temperature (judgement)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inappropriate periooperative temperature &gt;38.8&deg;C (judgement)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       <strong>",
"        Tachycardia",
"       </strong>",
"      </td>",
"      <td>",
"       Inappropriate sinus tachycardia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ventricular tachycardia or ventricular fibrillation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       <strong>",
"        Other",
"       </strong>",
"      </td>",
"      <td>",
"       Base excess below -8 mEq/L",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Arterial pH &lt;7.25",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rapid reversal of MH signs with dantrolene",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       <strong>",
"        Family history",
"       </strong>",
"      </td>",
"      <td>",
"       Positive history in a first degree relative",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Positive history in other relative",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Postive family history together with positive personal anesthetic history (not including elevated resting CK)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Resting elevated serum CK (in patient with postive family history)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33020=[""].join("\n");
var outline_f32_15_33020=null;
var title_f32_15_33021="Approach to dysuria in children and adolescents";
var content_f32_15_33021=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60818&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60818&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Approach to dysuria in children and adolescents",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 255px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33021=[""].join("\n");
var outline_f32_15_33021=null;
var title_f32_15_33022="Height velocity in children on hemodialysis";
var content_f32_15_33022=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F83843&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F83843&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 621px\">",
"   <div class=\"ttl\">",
"    Height velocity based on duration of dialysis and age in children on hemodialysis from the NAPRTCS registry",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 601px; height: 368px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Height Z score: the number of standard deviations from the mean height for age; NAPRTCS: North American Pediatric Renal Trials and Collaborative Studies.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2011 Annual Dialysis Report. Available at: https://web.emmes.com/study/ped/annlrept/annlrept.html.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33022=[""].join("\n");
var outline_f32_15_33022=null;
var title_f32_15_33023="Granulation tissue nr stent";
var content_f32_15_33023=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F75967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F75967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granulation tissue near stent",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 311px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_15_33023=[""].join("\n");
var outline_f32_15_33023=null;
